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I.1 Context and Justifications 
 
Diabetes and other chronic diseases used to belong to the western world. 
Currently, their incidence in the less developed countries is growing at a frightening rate. 
Excess consumption of energy-dense foods and considerable reduction of physical 
activities remain the main prevailing factors. In the past, farm work,  field activities, long 
walks between villages, daily wrestling, staple foods essentially based on cereals such as 
millet (long sugar polymers), and scarcity of soft drinks contributed to preserve 
populations against chronic diseases. This phenomenon caused public health specialist  
to think that continents such as Africa were of minor concerns regarding chronic diseases 
(WHO, 2004). 
Contrary to the past period, modern African societies are characterized by sophisticated 
transport systems, abundance of energy-dense foods (particularly in big urban cities), 
sedentary and European lifestyle. All these combined factors have contributed to the 
emergence of chronic diseases.  
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For instance, according to the World Health Organization (WHO) 2004 report, 143 000 
Senegalese suffered from diabetes in year 2000, whereas by 2030, if no action is taken, there 
will be 421 thousand (a 3-fold increase). This rate of increase is higher than those observed 
for the world because in the year 2000, 171 million people were recorded to be stricken by 
the disease worldwide and this number is expected to rise to 366 millions in 2030 resulting in 
a 2.14 fold increase. As for those countries known to have high mortality and morbidity rates 
due to the disease, a WHO report estimates that there will be just a 1.7 and a 1.4 fold rise in   
the USA and France respectively, thanks to the energetic measures taken by th se nations. 
Therefore, actions should be taken in order to tackle this overwhelming situation in Africa in 
general and Senegal in particular. Those actions should be achieved by way of an adequate 
and inexpensive nutrition therapy.  
In developed countries, in addition to nutrition education, several drugs have already been 
developed for chronic diseases management. However, due to their high costs and lack of 
availability, most individuals from developing countries, especially those from Africa, cannot 
afford them and  the long-term use of these drugs may be associated with detrimental side 
effects. Additionally, resources for nutrition education are limited.  
The alternative is to develop inexpensive functional foods from local products that provide 
compounds with properties scientifically verified to be potent in the treatment of chroni  
diseases such as diabetes and its associated complications. Aside from their basic nutritional 






Long-term goal  
Development of a functional food for diabetes care from fonio that was shown to have 
subsequent potential because of its high concentrations of beta-glucan, chromium, zinc, iron 
and important sulfur-containing amino acids (Traore 2004).  
Short-term goals  
(1) To investigate the possible modulatory properties of fonio and rice supplemented diets on 
inflammation and the pathogenesis of diabetes in KK/HIJ mice.  
(2) To investigate the effects of fonio extracts on inflammatory cytokines in healthy non-
diabetic CD1 mice.  
(3) To investigate the mechanisms by which fonio extracts modulate the secretion of 
inflammatory cytokines.   
1.3 Objectives 
(1) Four-week old KK/HIJ transgenic male mice will be fed either the AIN 93 diet or the 
same diet fortified with 30% fonio or rice flours (n=20). Ten mice per dietary treatment 
group will be sacrificed after 3 or 4 months of feeding. Glucose and insulin tolerance tests 
(GTT & ITT) will be measured by standard techniques. 
(2) Non diabetic healthy CD1 mice will be treated with bacterial lipopolisaccharides (LPS) in 
the presence and absence of fonio extracts. 
(3) Monocytic THP1 cells will be treated without and with different concentrations of fonio 







(1) Fonio, not rice, will significantly improve diabetic conditions in KK/HIJ mice. We define 
improved diabetic conditions as a decreased risk of developing insulin resistance, glucose 
tolerance, reduced weight gain, and down-regulation of the following pro-inflammatory 
cytokines: TNF-alpha; IL-6 and IL-1 beta.  The anti inflammatory cytokine IL-10 is expected 
to be lower in the fonio-fed KK/HIJ group. 
(2) The fonio extracts will induce in vivo and in vitro secretion of pro-inflammatory 
cytokines in the LPS-challenged CD1 mice. 
(3) Fonio extracts will modulate the immune response of monocytic THP1 cells via their 







REVIEW OF LITERATURE 
II.I Diabetes 
Definition                                                                                                          
Several types of chronic diseases characterized by impaired glucose metabolism resulting 
in elevated amounts of blood glucose due to alteration in insulin production or insulin 
action or their combined effects. The main and most discussed diabetes are the typ 1 and 
type 2 diabetes mellitus. They are different in their etiology, pathology and risk factors, 
therapy and evolution. Type 1 is an autoimmune condition which is present when the 
body creates self immunoglobulin to destroy its own pancreatic beta-cells. Although it 
can strike at any age, it mainly occurs in children and young adults (Dedoussis et al 2007; 
DeFronzo 2004; Hall and Davies 2008). Type 2 diabetes mellitus that is the focus of this 
present study starts its onset with the development of insulin resistance before reaching 
its final stage. Factors such as age, obesity, family history of diabetes or gestational 
diabetes, physical inactivity, race and ethnic group are risks that can prompt the disease. 
Diagnosis of diabetes 
The fasting plasma glucose (FPG) test. This is the first test administered in order to 
diagnose diabetes. it measures blood glucose in a person after an overnight fast of at least 
8 hours. The test is suitable to detect both diabetes and pre-diabetes.  A blood glucose 
level of 99 mg/dl or below is considered normal; Patients with values between 100 to 125 
mg/dl are considered pre-diabetic or insulin resistant. Those that have values of 126 or 
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above are considered diabetic clients. All these tests need to be replicated in differe t 
days before diabetes is confirmed. Although FPG is very convenient and low cost, it does 
miss some diabetes or pre-diabetes that can be detected with OGTT. Therefore additional 
tests are needed: 
OGTT. This is a more sensitive test especially for detecting pre-diabetes but invasive and 
less convenient.  The OGTT is performed after fasting for at least 8 hours prior to. The 
plasma glucose levels are measured immediately before and 2 hours after a person is 
given a water solution containing 75 grams of glucose. People whose blood glucose 
levels range between 140 and 199 mg/dl 2 hours after, have pre-diabetes also called 
impaired glucose tolerance (IGT).  
Having IGT, like having impaired fasting glucose (IFG), means that a person has not 
contracted diabetes type 2 but has an increased risk of developing it. But if a 2-hour 
glucose concentration of 200 mg/dl or above is detected and confirmed by repeating the 
oral glucose tolerance test on another day the person has diabetes. All these tests cited 
above (OGTT, FPG) require at least an eight-hour fasting period; HbA1C is a third test 
that is very precise in confirming the presence of diabetes and that doesn’t require the 
fasting period (Hawkins and Rossetti 2005; De Belvis et al 2009).   
HbA1C . Glycated hemoglobin (HbA1c) is considered an established measure of glucose 
control in people living with diabetes and is a measure of the degree of exposure to 
circulating blood glucose over time (Nair et al, 2011). With the improvement of its 
standardization, there is renewed interest in the potential use of HbA1c as a valid 
diagnostic test of diabetes. Recently, the International Expert Committee (IEC) (2009) 
proposed an HbA1c level of ≥ 6.5% to confirm the presence of diabetes, and ≥ 6.0% for 
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diagnosing impaired glycemic states. And in 2010, American Diabetes Association 
(ADA) officially recognized HbA1c as a diagnostic test recommending cut-points of 
≥6.5% for diabetes and 5.7–6.4% for high risk groups (American Association of Clinical 
Endocrinologists/American College of Endocrinology, 2010; HbA1c test results are also 
less variable than blood glucose measurements. The within-individual day-to-day 
variability is less than 2% for HbA1c, whereas variability with FPG ranges between 12–
15% for FPG and 16.6% for OGTT. But there are some limitations to the HbA1c test due 
to some important limitations such as hyperbilirubinaemia, elevated serum triglyce ides, 
pregnancy, age, genetic determinants (including race), pregnancy, malaria (Lapolla and 
colleagues 2011). 
Random Plasma Glucose Test.  According to the National Institute of Health 
(www.diabetes.niddk.nih.gov), blood glucose levels can be taken randomly. In this case, 
if values of 200 mg/dl or higher are found in people with the the following symptoms, it 
can be concluded that diabetes is present:  
Polyuria (increased urination)  
Polydipsia (increased thirst)  
Unexplained weight loss  
Other symptoms such as fatigue, blurred vision, increased hunger, and sores that do not 
heal will also be considered. Then the FPG test and/or OGTT are performed another day 
to confirm the diagnosis (www.diabetes.niddk.nih.gov).  
Risks factors                                                                                                   
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 Weight. Being overweight or obese is a primary risk factor for type 2 diabetes. Fatty 
acids levels are directly related with the development of insulin resistance (Mokdad et al 
2003).  
Fat distribution. If your body stores fat primarily in your abdomen, your risk of type 2 
diabetes is greater than if your fat stores are located in your hips and thighs (Folsom et al 
2000). 
Inactivity/sedentarism. Low activity level increases chances to develop of diabetes type 
2. Physical activity helps control weight. Ingested glucose and other starchy foods are 
used as energy (mostly ATP) and cells become more sensitive to insulin. Also low 
activity is strongly correlated to early death in people with diabetes typ  2 (Colditz and 
Mariani 2000; Church et al 2004)  
Family history. The risk of type 2 diabetes increases if your parent or sibling has type 2 
diabetes (Bochud  et al 2004; Barone et al 2008) 
Race. Blacks, Hispanics, American Indians and Asian-Americans are more likely to 
develop type 2 diabetes than whites. Reasons are still unclear (Stuart  et al 2000; 
Davidson and Schriger 2010). 
Age. The risk of type 2 diabetes increases with age, especially after age 45. This is ma nly 
due to a decrease in exercise that leads to a rapid loss of muscle mass with an increased 
weight gain with age. But the incidence of diabetes type 2 is also increasing dramatically 
among children, adolescents and younger adults (Fagot-Campagna et al 2005; Barone et 
al 2008). 
Prediabetes/insulin resistance. As the blood glucose level rises after a meal, the pancreas 
releases insulin to help cells take in and use the glucose. Prediabetes is a condition in 
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which your blood sugar level is higher than normal, but not high enough to be classified 
as diabetes type 2. Left untreated, prediabetes often progresses to type 2 diabetes
(DeFronzo, 2004). An impaired insulin secretion derives from several factors such as a 
defect in proinsulin biosynthesis, glucose toxicity, beta-cell dysfunction, and lipotoxicity 
(Kahn, 2001). Among all the above cited factors, beta cell dysfunction is considered a 
common trait in diabetes type 2 (Leahy 1990; Weyer et al 1999). Also beta cells 
dysfunction combined with fat accumulation lead to insulin resistance (Hawkins, 2005). 
Aggravation of insulin resistance interrupts normal physiologic actions of the hormone 
triggering the development of hyperinsulinemia that will eventually develop int  d abetes 
type 2 and other conditions such as hypertension, dyslipidemia, atherosclerosis, and 
malignancy (Folsom et al, 2000; Calle et al, 1999). 
High LDL/low HDL. Studies show that high levels of LDL combined to low levels of 
HDL led to the development of type 2 diabetes (ADA, 2008; Stumvoll et al, 2009). 
Hypertension. Weycker and colleagues showed that all persons with hypertension, 
irrespective of age, sex, and BMI, had considerable risks of contracting diabetes. Among 
them, those that are overweight or obese are at substantially elevated risk of diabetes, 
regardless of age (Weycker et al, 2009). 
Environmental factors/genetics. Figure 1 describes how environmental factors directly 
interact with susceptibility genes into the development of type 2 diabetes or via obesity, 




Figure1 Interrelation between genes and environmental factors in type 2 diabetes 
(Dedoussis et al, 2007. Rev Diabet Stud. 4(1):13-24. Epub). 
II.2. Cytokines 
When challenged The  immune system reacts by putting into play several white blood 
cell types, but the communication between those cells is mainly mediated by solu le 
factors recently known as cytokines (Gordon et al, 2008). Figure 2 (Munoz et al, 1995) 
describes the events leading to production of several cytokines when macrophages were 
challenged with lipopolysaccharide (LPS). During the last decade, more than 30 factors
11 
 
have been purified with their primary structures described and their genes d termined and 
cloned by recombinant DNA methods (Munoz et al, 1995). The body can recognize 
antigens and initiates the transcription of various cytokine genes that are translated in the 
cytosol and secreted into the extracellular space, and alike hormones they transmit their 
biological signals mostly by binding by high or loose affinity to specific ligands (cell 
surface receptors) thus triggering needed biological activities to protect targe ed cells or 
organs. Apart from being pleiotropic and redundant in their actions, it is important to 
know that cytokines are mostly interdependent since the presence of another one or 
others can drastically change the direction of action of a given cytokine (for instance one 
cytokine that normally upregulates a biological action can downregulate it with he 
presence of another one [1]. The pro-inflammatory cytokines production is essential to a 
correct response to inflammatory status but an excessive production of them may be 
detrimental since resulting in most cases in an increase morbidity and mortality. 
Antioxidant defenses are exhausted that can lead to cells and tissue damage (Gordon et 




Figure 2. Positive and negative signals on cytokines production. Reproduced from the 
works of Munoz and his colleagues (Munoz et al, 1995). 
Role of cytokines as therapeutics 
Manipulation of cytokines has been a novel science and a tremendous breakthrough in 
the treatment of many diseases (Vilcek and Feldmann, 2004) that can clearly be separated 
in two distinct strategies. On the one hand, the over-expression of harmful cytokines are 
reduced or blocked by the administration of therapeutics, nutraceuticals or other die ary
compounds and on the other hand, purified recombinant cytokines are administered to 
induce a positive physiological activity resulting in soothing or curing an ailment. 
Hematopoietic growth factors (colony stimulating factors) and interferons ca  be cited as 
successful cases in the treatment of diseases. 
Characterized around 1950, cytokines are composed of regulatory proteins that are 
mainly produced by white blood cells and other cell types of humans and other animals. 
They have a wide range of actions among which the regulation of the immune system. In 
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1953, Bennett and Beeson demonstrated the existence of Interleukin 1 (IL-1) by treating 
normal rabbits with either extracts of tissues and or polymorphonuclear leukocytes 
collected from sterile peritoneal exudates in quantities of 200 to 600 million suspended in 
sterile physiological saline. These peritoneal exudates were obtained from normal rabbits 
that were challenged by Serratia marcescens endotoxin. The extracts of tissues did not 
produce any effect but those of the polymorphonuclear leukocytes contained a heat-labil  
substance or fever-producing agent that produced fever in the febrile animals that 
reflected inflammation. Then, for the first time, Il-1 was evidenced and named s pyrogen 
(Bennett and Beeson, 1953). Also, the supernatants fluids obtained from the original 
peritoneal exudates exerted the same fever-producing activity. They concluded that the 
polymorphonuclear leukocytes that were producing fever in the rabbits were identical to 
those that would proliferate, produce heat and dye during acute injury. But carefully, they 
stated that other cells that appeared to be inactive should not be excluded from being 
capable of producing fever in different conditions or amounts.  
Since then many studies were conducted on how IL-1 were involved in the pathogenesis 
of several diseases. Recently, an IL-1 inhibitor in the form of a soluble IL-1 receptor 
antagonist was approved for therapeutic use against rheumatoid arthritis. Te mechanism 
of action involved is the prevention of active IL-1 from its receptor. The researchers 
recruited a total of 412 RA patients (18-75 of age) from centers of 11 European countries 
that were randomized into 4 groups: placebo (n = 121) or IL-1Ra at a daily dosage of 30 
mg (n = 119), 75 mg (n = 116), or 150 mg (n = 116). Two methods (Genan and Larsen 
erosive joint count) of hand radiographs were performed at baseline, 24 weeks, and 48 
weeks and scores were recorded. Significant reductions in the score for progression of 
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joint space narrowing (JSN) of 58% and a decrease in erosion (38%) and a combined 
reduction of 47% of JSN and erosion as total score were observed in all treatment groups 
at week 24. IL-1Ra reduced radiologic progression of RA. Both methods used strongly 
correlated for each individual time point from baseline (0.83 with P < 0.0001 for both 
methods), but much less strongly for assessments of disease progression betweew ek 
24 to week 48 (0.36 and 0.41 (P < 0.0001 respectively for the Genan and Larsen 
methods). 
Several studies indicate that pro-inflammatory cytokines may play roles in eating 
disorders. The pro-inflammatory cytokines such as IL-1, IL-6, TNFα are known to 
decrease food intake. They mediate infection and inflammation during the anorexi  as 
part of a of a sickness response (Wong and Pinkney, 2004).  These cytokines are believed 
to influence the energy balance by their actions on the appetite-regulating p hways of 
the brain; they can follow three different itineraries to reach the neural targets: via the 
vagal afferents route, or by direct contact with the cerebral epithelium or reaching the 
brain by passive diffusion in regions that are not tightly covered by the blood brain 
barrier. Deregulation of the cytokine network may be the primary cause for medical 
complications in patients with anorexia who suffer from chronic underweight (Wong and 
Pinkney, 2004).  
Similarly, Dantzer examined whether an increase in local proinflammatory cytokines 
would be associated with increased negative mood and decreased positive mood. For that 
purpose,189 healthy adults were recruited and exposed to rhinovirus or influenza virus 
during a 6-day period of quarantine and the outcome variables at baseline and on each f 
the 5 post-challenge quarantine days were infection, objective signs of illness, nasal IL-
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1β, IL-6, and TNF-α, and self-reported affect. In the 153 persons who became infected 
following exposure to the challenge virus, daily production of the three cytokines, was 
associated with reduced concurrent daily positive affect. Findings support a causal 
association between pathogen-induced local cytokine production and changes in positive 
affect over a 24-hour time line. Therefore, IL-1, IL-6, and TNF-α, were not only 
responsible for the local inflammatory response, but in addition, they synchronize the 
physiological and behavioral components of the systemic acute phase response to 
infection. In addition, they induced a behavioral pattern referred to as sickness behavior, 
including anorexia, psychomotor retardation, sleep disturbances, pain, anergy, and 
anhedonia that is the inability to experience pleasure [2].  
Role of cytokines in diabetes and chronic diseases                                        
Tuttle and coworkers showed that the pro-inflammatory cytokines IL-6 and TNF-alpha 
were chronically increased among type 2 diabetic women with or without cardiovascular 
diseases (CVD) compared to non-diabetic women. They also reported that inflammation 
was involved in diabetes pathogenesis (Tuttle et al, 2003). Beta-cell apoptosis was 
reported to be mediated by nitric oxide (NO) presence and oxygen-derived free radicals; 
the beta-cells under stress express very low levels of free radical scavenging nzymes 
(superoxide dismutase and catalaze) leading to increased suceptibility to free radical-
induced beta-cell damage (Kawasaki, 2004). Also IL-1 alone or associated with INF-
gamma led to the beta-cell synthesis of NO and other cytokines to trigger cell apoptosis 





Obesity, Inflammation and diabetes 
Not long ago, TNF-alpha was identified as the first molecular link between 
inflammation and obesity. This inflammatory cytokine was found to be over-expressed in 
the adipose tissues of rodent models of obesity (Hotamisligil et al, 1993; Sethi and 
Hotamisligil, 1993) 
Recently, many studies investigated how cells behave under the stresses of obesity. Major 
breakthroughs had been done in the understanding of the intracellular signaling pathways 
activated by inflammatory and stress responses and how these pathways influence and 
inhibit insulin signaling. 
Insulin initiates cells response through binding to its receptor on the surface of insulin-
responsive cells. This binding stimulates an auto-phosphorylation of the insulin receptor 
that triggers the phosphorylation of several substrates, including members of the insulin 
receptor substrate (IRS) (White, 1997; Saltiel and Pessin, 2002). Exposure of cells to
TNF-alpha and/or high levels of free fatty acids blocks the phosphorylation of serine 
residues of IRS-1 (Yin et al, 1198; Aguirre et al, 2000). Without phosphorylation of the 
serine residues, association of IRS-1 with the insulin receptor is not allowed.  Th refore, 
the downstream signaling is practically shut down, and consequently insulin action is 
drastically reduced. (Paz et al, 1997; Aguirre et al, 2002). This is a primary mechanism 
through which inflammatory signaling (via TNF-alpha) leads to insulin resistance. 
Nutrition and Inflammation 
Nutrition status plays a major role in infection. People with a good health and nutritio al 
status respond by producing enough inflammatory cytokines when they experience 
infection. Whenever the immune system gets rid of the infection, the inflammatory 
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cytokines are cleared (Gordon et al, 2008). However when malnutrition is present, the 
body doesn’t produce enough inflammatory cytokines in case of infection and these 
populations become highly sensitive to infectious diseases (Neumann et al, 1975).  
Protein-energy malnutrition (PEM). Studies have shown that it is the loss of lean 
(protein) rather than fat tissue that has the most critical clinical impact. For instance, 
Neumann and colleagues (1975) studied the immunological response of normal and 
malnourished Ghanaian children; and they evidenced for the first time, that cytokine 
production was impaired in protein-energy malnutrition (PEM). Results of their sudy
showed that malnourished children had four times the amount of infection and a 20% 
increase in parasitic infestation rates as compared to normal children. Also they (PEM) 
had lower circulating concentrations of the acute phase protein and C3 complement.  
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Table 1: Cytokine Production in protein-calorie malnourished subjects (from Neumann 
et al, 1975)
 
Later on, Hoffman-Goetz and his colleagues (1981) reported that leukocytes from 
patients suffering from PEM on admission produced low levels of interleukin-1 alpha 
(IL-1alpha) after being challenged with LPS.  After nutritional rehabilittion (via total 
parenteral nutrition) , their response became normal. 
Lipids modulate the immune system by altering membrane fluidity, producing lip d 
peroxides, regulating eicosanoid metabolites and interacting with cellular activation 
processes. 
Lipids. Epidemiological studies in populations of coastal Eskimo, Japanese and Dutch 
subjects have shown that a high intake of n-3 fatty acids correlates with a low incidence 
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of cardiovascular and inflammatory diseases such as asthma and Type I diabetes melli us 
Siess et al, 1980; Strasser 1985, Kromhout 1990). 
The above findings are recently explained by the fact that sea foods are rich in n-3 
polyunsaturated fatty acids (PUFA) such as eicosapentaenoic acid (EPA, 20:5 n-3) and 
docosahexaenoic acid (22:6 n-3); and they are very low in arachidonic acid (20:4 n-6) 
[Jump, 2002].  EPA and arachidonic acid are further metabolized to eicosanoids and 
eventually to prostaglandins (PG), thromboxanes (TX) and leukotrienes (LT) via the 
cyclooxygenase (PG, TX) and lipoxygenase pathways (Jump, 2002).  Eicosanoids have 
several physiological functions including:  mediation of inflammation, and aggregatory 
and vasoconstrictory effects (. Eicosanoids derived from n-3 fatty acids are anti or less 
proinflammatory (PGE3, LTB5). EPA-derived PG inhibit TXB2-mediated platelet 
aggregation and promote vasodilation derived from arachidonic (n-6) acid are pro-
inflammatory (prostaglandin E2, PGE2; leukotriene B4, LTB4), potent vasoconstrictor 
and platelet activator (TXB2) [ 
II.3. Digitaria exilis (fonio)  
Fonio is a variety of millet mainly grown in West Africa, consisting of tiny kernels with a 
size approximating 700 µm of diameter. According to the geographic location, it is given 
different names such as “Acha” or “Fundi”; its English name is “hungry rice” (Sartelet, 
1995). 
Habitat                                                                                                                   
According to National Academy of Sciences (1996), fonio is probably the oldest African 
cereal and was being cultivated across the arid savannas. This cereal in fact was used as 
the major staple food. Nowadays the crop still remains important in areas scattered from 
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Cape Verde to Lake Chad. In certain rural regions of Mali, Burkina Faso, Guinea and 
Nigeria, it is still heavily consumed but the incidence of diabetes in these particular 
regions is not yet documented. Compared to the other cereals, fonio has received little 
attention due to the fact that scientists and other decision makers have misunderstood the 
plant. This neglect, characterized by few publications, was brought about by English 
colonialists who knew little about the cereal and called it “hungry rice”, a misleading 
term. In fact local populations harvested fonio not because of hunger but because they 
liked its taste (National Academy of Sciences, 1996); and because of its ability to 
withstand infertile soils and low rainfalls in the Sahelian regions (Sartelet, 1995). 
In some places fonio is particularly reserved for chiefs, royalty and special oc asions 
such as ancestor worship.  Harlan (1993) reported that according to the Dogon tribe in 
Mali, the whole universe emerged from a seed of fonio. Harlan made the following 
statement on fonio: “First, let me call attention to some of the other cereals, both wild and 
tame. Fonio or acha, Digitaria exilis, has been given the misnomer "hungry rice" by 
English colonials. It is not grown to relieve hunger but because of its quality. It is a
chief's food, a gourmet item, and couscous made of fonio is better than couscous made 
from wheat’’.  
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Biochemical properties                                                                                      
Fonio is reported to be different from other cereals in that it displays the lowest amino 
acid pattern but offers the singularity of being much richer in methionine and cysteine 
(sulfur-containing amino acids) and leucine whose concentrations are higher than those 
defining the FAO reference protein (Sartelet et al, 1996; Thompson et al 1993; Becker et 
al, 1986). 
Also, fonio has less flavonoid contents when compared to the other cereals with 500 
mg/kg against 1 to 1.2 g /kg from Pennisetum millet and Pennisetum americanum. But in 
the latter cereals, the types of flavonoids are composed of C-glucosyl derivatives (less 
goitrogenic); fonio once again differs from those species by containing two aglycones 
(150 mg of apigenin and 350 mg of luteolin) that are approximately seven times more 
potent than C-glucosyl derivatives (Sartelet et al, 1996).  This feature implies that the 
lower content of flavonoids in fonio is compensated by the presence of the most active 
ones. In addition, contrary to the millet species, fonio did not contain thioglucosides or 
cyanogenic glucosides that are transformed after hydrolysis or bioconversion into 
thiocyanates known to be goitrogenic compounds (Van Etten et al, 1973; Delange et al, 
1976). 
In their study, Sartelet and his colleagues showed that luteolin from Fonio showed a 
regulatory effect on thyroid functions of pig thyroid cells. First, they demonstrated that 
both luteolin and apigenin had inhibitory effects on thyroid hormone production by 
impairing thyroid peroxidase activity; however, luteolin displayed a highly stimulatory 
effect on thyrotropes on day 4 of treatment, through deactivation of cAMP 
phosphodiesterase, thus allowing a highly significant overproduction of the second 
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messenger cAMP nucleotide that is dependent on the thyrotropin-stimulating hormone 
(TSH) action on thyrotropes. But the net result of these opposing effects was slightly
goitrogenic. 
They concluded that further studies should be conducted to better elucidate the role, 
function and mechanism of action of the fonio aglycones on thyroid hormones (Sartelet et 
al, 1996).   
Nutritional aspects.                                                                                                           
The proximate composition of white fonio is comparable to wheat with the husked grain 
containing 8 percent protein and 1 percent fat. In some black fonio samples, the protein 
content was 11.8 (National Academy of Sciences, 1996). Becker and later on De 
Thompson showed that the difference with the other cereals was the amount of the 
essential amino acids, especially the sulfur containing ones: approximately 7.3-8.0 % of 
the amino acids in fonio protein are methionine and cysteine. The amino acid profile 
compared to that of whole-egg protein showed that except for the low score for lysine 
46%, the other scores were high: 72 for isoleucine, almost 100 for valine, tryptophan, 
threonine and phenylalanine; 127 for leucine; 175 for total sulfur and 189 percent for 
methionine (De Thompson et al 1993; Becker et al, 1986). These figures show the 
important potential of Fonio, not in terms of a survival crop but as a standard diet (De 
Thompson et al 1993; Becker et al, 1986). In addition, a study in 2004 (Traore, 2004) 
showed that fonio was rich in beta-glucan and chromium, two compounds known to 
display important beneficial effects on diabetes. Beta-glucan has been extnsively studied 
and reviewed for its alleged properties to deal with chronic diseases (Volman et al. 2008; 
Brown and Gordon, 2003; Burkitt et al 1981). The importance of fiber, beta-glucan, 
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chromium the sulfur containing amino acids and their interaction with diabetes will be 
further reviewed.  
II.4 Effects of fonio active compounds on diabetes 
As previously mentioned, late studies on fonio revealed that the cereal was rich in dietary
fibers containing subsequent quantities of beta-glucan. In addition the cereal displayed 
important amounts of chromium and sulfur-containing amino acids.  
As early as 1960, has there been an ongoing growing interest in the study of the positiv
health effects of dietary fibers. Researchers have so far succeeded in mapping out their 
molecular components, molecular weights, and physical properties in order to have a
better understanding of their functions in the human body. Both human and animal 
models have been used to directly assess beta-glucan effects and their mode of actions. 
One of the important components of dietary fibers that investigators thought to be among 
the more potent was beta-glucan, a soluble dietary fiber present in some cereals and some 
mushrooms. Beta-glucans have been extensively studied; and most of the related 
beneficial health effects from dietary fibers have been associated with them. Some works 
on beta-glucan confined themselves to their prebiotic properties; others, to their 
capability of lowering blood glucose and potentiating insulin action or to their potential 
of boosting the immune system and consequently, their capability to fight against certain 
chronic diseases that impair the immune system (diabetes, hypertension, cardiovascular 
diseases and cancer). 
Several models have been proposed to explain how they interact with the human body. 
Some mechanical effects have been clearly defined when dietary fibers bind cholesterol 
in the gut to excrete it in the feces and not allowing its re-uptake via the enterohepatic 
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pathway circulation. But it is not long ago that researchers really started to break through 
beta-glucan functions at the molecular level. Also, chromium was known as a co-factor 
of insulin that would potentiate ita action on glucose and fat metabolism, but recently 
several studies showed that the tracemineral was involved in several inflammatory 
processes. As for sulfur-containing amino acids, there is a paucity of data or studies 
relating them directely their effects on diabetes and its complications. But the effects of 
other sulfur-containig compounds on diabetes have been extensively investigated. The 
objective of this review is to start with a brief presentation of the chemical structures and 
characteristics of these selected compounds, then give an overview of their metabolism, 
their role against chronic diseases in general and diabetes in particular in order to further 
discuss their immune modulating properties. 
Chemical structure of β-Glucans                                                                          
  β-Glucans are composed of several linked glucose molecules, which are major structural 
components of the cell walls of yeast, fungi and some bacteria (Figure 1). Also cereals, 
such as barley and oat contain β-glucans as part of their endosperm cell walls. Depending 
on the source, there are clear differences in macromolecular structure betwe n β-glucans 
(Figure 2). The cell wall β-glucans of yeast and fungi consists of 1,3 β-linked 
glycopyranosyl residues with small numbers of 1,6 β-linked branches. In contrast, cereals 
(oat and barley) cell walls contain unbranched β-glucans with 1,3 and 1,4 β-linked 
glycopyranosyl residues, whereas β-glucans from bacterial origin are unbranched 1,3 β-
linked glycopyranosyl residues (Volman  et al. 2008). Furthermore, besides differences in 
type of linkage and branching, β-glucans can vary in solubility, molecular mass, tertiary 
structure, degree of branching, polymer charge and solution conformation (triple or single 
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helix or random coil). All these characteristics may influence their immune modulating 
effects. For example, Brown and Gordon (2003) have recently suggested that high 
molecular weight (MW) and/or particulate β-glucans from fungi directly activate 
leukocytes, while low MW β-glucans from fungi only modulate the response of cells 
when they are stimulated with cytokines. With respect to the characteristics of he β-
glucans, it should be noted that the isolation method may influence these characteristics. 
Consequently, differences can be expected between various β-gl cans differentially 
isolated from the same source (Volman et al. 2008).  
Physiological effects of β-glucans                                                                            
It has been suggested that diabetes mellitus is highly correlated with the fiber-depleted, 
highly-refined carbohydrate diet of the “civilized man” (Burkitt 1981). Population 
studies, as well as clinical and experimental research showed diabetes as being one of the 
diseases most clearly related to inadequate dietary fiber intake (Burkitt et al 1981, 
Vahouny et al 1982). These results indicate that while the intake of refined sugarshould 
be curtailed, the intake of complex carbohydrate sources that are rich in fiber should be 
increased.  
The term “dietary fiber” refers to the components of the plant cell wall as well the 
indigestible residues from plant foods. The types of fiber that exert the most beneficial 
effects on blood sugar control are the water-soluble forms. Included in this class are 
hemicelluloses, mucilage, gums, and pectin substances. As early as 1981, one study 
(Simpson et al 1981) showed that these types of fibers were capable of slowing the 
digestion and absorption of carbohydrates, thereby preventing rapid rises in blood 
glucose; increasing the sensitivity of tissue cells to insulin, thus preventing the excessive 
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secretion of insulin; and improving uptake of glucose by the liver and other tissues, 
therefore preventing a sustained elevation in blood sugar.  
In the study cited earlier, a high carbohydrate, legume rich, high fiber diet improved all 
aspects of diabetic control. Other studies showed that when diabetic patients were 
supplemented with 14 and 26 grams of guar gum per day, they required less insulin and 
had less glycosuria (Vahouny et al 1982, Jenkins, 1980).  
Both crude fibers and total dietary fibers contribute to the lowering of the glycmic index 
of foods (Jenkins et al, 2002) and are inversely related to body mass index (Mckeown et 
al 2002), HbA1c levels and ketoacidosis risk (Toeller 2002). The glycemic index 
concept, an extension of the fiber hypothesis, suggests that fiber consumption reduces the 
rate of nutrient influx from the gut, and as a result significantly improves glycemic 
control in diabetic clients. Also, fiber consumption reduces urinary C-peptide excrtion in 
healthy people as well as circulating insulin and serum lipids in hyperlipidemic subjects 
(Jenkins et al, 2002; Giacco et al, 2002). And consumption of high fiber diets has been 
associated with higher HDL-cholesterol concentrations in cohort studies, with decreas d 
risk of developing diabetes and cardiovascular diseases (Kumar et al 2002; Simin 2002; 
McKeown et al 2002; Mujumdar, 1995).  
Viscosity and molecular weight as physiological determinants 
The physiological functions of dietary fiber are often attributed to their physico-chemical 
properties: water holding capacity, swelling, diffusion-suppressing ability (through 
viscosity enhancement and gel-formation), binding properties, and susceptibility or 
resistance to bacterial degradation and fermentation (Dikeman and Fahey 2006). The 
mechanisms by which a soluble fiber, such as β-glucan, exerts hypocholesterolemic and 
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hypoglycemic effects are still debated but the most common hypothesis is based on 
increased lumen viscosity (Battilana 2001 et al., Dikeman and Fahey 2006). It has been 
suggested that cereal β-glucans decrease the absorption and reabsorption of cholesterol, 
bile acids, and their metabolites by increasing the viscosity of the gastro-intestinal tract 
contents as well as delaying gastric emptying and the intestinal absorption of nutrients, 
such as digestible carbohydrates, and thereby reducing post-prandial hyperglycemia and 
insulin secretion. The latter have health benefits for those with type-2 diabetes, and are 
also associated with reduced risk of developing the disease and insulin insensitivity.                         
Carbohydrate and lipid metabolism are closely interrelated and insulin has also been 
reported to increase hepatic cholesterol synthesis. Therefore, if fiber decreases 
carbohydrate absorption and insulin secretion, it may also contribute indir ctly to the 
hypocholesterolemic effects (Dikeman and Fahey 2006, Wood et al. 2002). Bell et al., 
1999 S. Bell, V.M. Goldman, B.R. Bistrian, A.H. Arnold, G. Ostroff and A. Forse, Effect 
of β-glucan from oats and yeast on serum lipids, Critical Reviews in Food Science and 
Nutrition  (1999), pp. 189–202. Abstract | View Record in Scopus Cited By in Scopus 
(36)Furthermore, the increased viscosity caused by soluble dietary fibe  influences fat 
emulsification by increasing emulsion droplet size which may impair fat absorption 
(Pasquier et al. 1996). However, Battilana and his colleagues (2001) found that the 
administration of frequent meals with or without β-glucans resulted in similar 
carbohydrate and lipid metabolism, whereas ingestion of a single meal containing β-
glucan lowered post-prandial glucose concentrations. This might suggest that the 
beneficial action of β-glucans is mainly due to delayed and reduced carbohydrate 
absorption from the gut and does not result from the effects of metabolites produced by 
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fermentation of β-glucans in the colon. It is also likely that β-glucans do not only 
decrease the post-prandial glucose response due to high viscosity in the gastro-intestinal 
tract, but also reduce starch digestion by α-amylase. Symons and Brennan (2004) found 
that inclusion of 5% of a β-glucan-rich fraction in bread resulted in a significant decrease 
in the release rate of reducing sugars following the in vitro digestion of bread with pepsin 
and α-amylase. A study with ileostomy subjects showed that bile acid excretion increased 
by a mean of >50% in a diet with oat bran bread, compared with a simil r diet in which 
70% of the β-glucan was degraded by β-glucanase. This indicates that the high molecular 
weight β-glucan mediates increased excretion of bile acids: whole micelles or bile acids 
may become entrapped or encapsulated in the highly viscous β-glucan matrix, and then 
excreted from the small bowel or the viscous environment to reduce the formation of 
mixed micelles in the small intestine and/or decrease the reabsorption of bile acids in the 
terminal ileum (Lia et al. 1995).  
Furthermore, a dependence of the hypocholesterolemic action on extractability, viscosity, 
pseudo-plastic flow behavior, hydrodynamic properties, and molecular weight of β-
glucans was found in rats fed on diets based on various oat bran concentrates, supporting 
a mechanism based on high lumen viscosity (Malkki et al, 1992). A differenc  in the 
mechanism of physiological effects has also been observed between cereal β-glucans 
differing in their molecular features. Wilson and his colleagues (2004) demonstrated that 
the cholesterol-lowering activity of barley β-glucan in hamsters occurred with both low 
(175 kDa) and high molecular weight (1000 kDa) preparations. Several other animal 
studies of diets supplemented with cereal fiber or cereal fractions showed that the content 
of β-glucans and particularly that of soluble β-glucans, the molecular weight of the β-
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glucans and endogenous β-glucanase activity, all of which affect extract viscosity, 
appeared to be strong predictors of the serum cholesterol response (Kahlon 1993 et al., 
Newman and Newman, 1991; Newman et al, 1992) . In a meta-analysis report, Brown et 
al (1999) identified 25 clinical studies involving a total of 1600 healthy, hyperlipidemic 
and diabetic individuals in the age range of 26–61. Daily doses of between 2 and 10 g of 
oat soluble fibers gave significant mean reductions in the total (−0.04 mmol/L/g of fibre) 
and low-density-lipoprotein (LDL, −0.037 mmol/L/g of fibre) cholesterol levels. It is 
generally considered that the cholesterol-lowering effect is larger in subjects with higher 
cholesterol levels, whereas the dose–response effect is not always clear.  
Overall, the findings from many human studies reveal a substantial variation in the 
responses between the different trials and types of subjects studied. In addition to 
variation in the design (intervention) of the clinical trial (i.e. number and type of subjects 
involved, daily intake and number of servings, length of treatment, etc.) variation is also 
observed in the physiological responses of individuals. Also, in some cases, inconsistent 
results may be related to factors that influence the viscosity development by β-glucans, 
which is in turn determined by the molecular weight and extent of solubilization of the 
polysaccharide from the food matrix. 
According to Anderson et al. (1990) and Mallki and Virtanen (2001), soluble fibers can 
affect satiety and promote weight loss for a number of reasons including a slower rate of 
meal intake, a delay in gastric emptying, moderate responses of plasma glucose levels 
and insulin secretion by the pancreas (insulin stimulates hunger), elevation of 
cholecystokinin (a gut hormone correlated with prolonged satiety) and production of gas 
and short-chain fatty acids by fermentation of the fibers in the colon. 
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A gelling β-glucan from barley (Glucagel) can cause a number of effects on the 
mammalian immune system, including upregulation of the release of the cytokine 
interleukin 1β (IL-1β) (indicating enhanced monocyte differentiation), changes to wound 
healing processes and enhancement of gut mucin secretion (Porter  et al. 2006). 
Furthermore, the in vitro secretion of IL-1β, which is one of the early responses of the 
immune system to infection, increased as the dose and molecular weight of the β-glucan 
were increasing.  
Effects of β-glucans on food matrix                                                               
 The viscosity effects of β-glucans are often modulated by formulation and food 
processing and storage protocols. The dose–response of oat gum on plasma glucose and 
insulin levels of healthy humans consuming oat gum in a drink (in the range of 1.8–
14.5 g after an oral glucose load of 50 g) has been studied (Wood 1994). Increasing the 
dose of oat gum successively reduced the plasma glucose and insulin responses relativ  
to a control drink without gum, reaching a plateau dose–response at an intake of 6 g of β-
glucan (the maximum effective dose). In a recent study by Cavallero et al. (2002), a 
linear decrease in the glycemic index of non-diabetic humans was found with increasi g 
consumption of barley β-glucan in bread, the GI (glycemic index) being related to the 
total β-glucan content (TBG).  
Digestion and metabolism of β-glucans                                                      
When ingested, beta-glucan starts to absorb water and swell. The rate of swelling and 
dissolving depends on the particle size and previous hydrothermal treatments. Increased 
volumes cause a distension of stomach affecting satiety. Data on the effect on gastric 
emptying are in part controversial. A concept often referred is that viscous dietary fibers 
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reduce the rate of gastric emptying, whereas coarse particles leav  the stomach sooner 
(Wilmshurst and Crawley 1980).  Only 0.16 or 0.13 of the beta-glucan given in the form 
of rolled oats or oat bran, respectively, was dissolved 1 h after feeding, and was 
transferred into the duodenum (Wilmshurst and Crawley 1980).  
In addition to the effect of viscosity as such, a possible mechanism for the retardation of 
gastric emptying is the effect of products of colon fermentation. When non digested 
carbohydrates enter the proximal colon, they are fermented to short-chain fatty acids 
(SCFA), which decrease the gastric tone (Ropert et al. 1996). 
Small intestine. As the mammalian enzymes are unable to hydrolyse beta-glucan, it 
remains nearly intact in the small intestine of healthy man and thus increases the viscosity 
throughout the small intestine. The increased viscosity caused by viscous polysaccharides 
has the following effects on the digestion and absorption: 
• Hindered mixing of luminal contents may retard transport of digestive 
enzymes to their substrates (Schneeman and Gallaher 1985).  
• Emulsification of lipids is impaired, partly due to decreased mechanical 
mixing caused by the reduction of the contraction movements (Edwards et 
al. 1988). 
• Reduced absorption of nutrients due to retarded transport to the absorbing 
surface and to the increased thickness of the unstirred layer on the 
absorbing surface (Edwards et al.1988).  
The retarded absorption of nutrients has been often ascribed to reduced diffusion rates. 
However, model experiments with guar gum (Edwards et al. 1988) have shown that it is 
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mainly due to increased resistance to contraction movements, and thus decreased mass 
transfer by convection. 
Lipid digestion and absorption in the intestine. As shown in an in vitro study (Pasquier et 
al. 1996), viscous fibers affect the emulsification of lipids by causing an increase in lipid 
droplet size and thus a decrease in the contact surface between the lipid and aqueous 
phase. A study of ileostomic patients (Lia 1997) showed that oat bran in the test meal 
delayed the micellar lipid solubilization process and consequently reduced the secretion 
of chylomicrons into the circulation. In an earlier study by the same group (Dubois et al. 
1995), it was found that 3 h after a meal containing 40 g oat bran, corresponding to about 
5 g of soluble oat fiber, the level of the large-sized triglyceride rich lipoprotein fraction of 
blood was higher than the control meal 3 hours later. This increase was still higher after 
the subjects had been adapted to the oat bran diet for 14 days. In a number of other 
clinical studies, oat bran or oat gum has been found to reduce lipid absorption.  
Mechanism underlying the effect of β-glucans on the immune system 
 After oral administration, β-glucans come in contact with the mucosal immune system 
(Figure 4). The intestinal epithelial cells together with the immune cells of the Peyer’s 
patches play an important role in regulating immune responses. Oral administration of β-
glucans can modulate the mucosal immune response by cells of the Peyer’s patche as 
well as intestinal intraepithelial lymphocytes (Tsukada et al. 2003). It has been suggested 
that the protective effects of orally administered 1,3 β-glucans are mediated through 
receptor-mediated interactions with microfold cells-specialized (Figure 5) epithelial cells 
for the transport of macromolecules-in the Peyer's patches, which lead to increased 
cytokine production and enhanced resistance to infection.  
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Effects of various β-glucans have been examined in vitro and in several animal models, 
while only a few human studies have been carried out. Three clinical studies 
demonstrated that pre-treatment of high-risk surgical patients with poly-[1-6]- D-
glucopyranosyl-[1-3]--D-glucopyranose glucan (PGG-glucan) supplied intravenously 
(Abbas & Lichtman 2003) decreased the infection incidence and need for antibiotics, 
shortened intensive care unit length stay, and ultimately improved survival compared to  
saline placebo injection (Babineau et al. 1994, Babineau et al.1994). Only 3 days after 
trauma serum IL-1 concentrations were elevated in β-glucan treated trauma patients as 
compared to control treated patients, while TNFα concentrations remained unchanged 
(Browder et al. 1990). Similarly, Lehne et al. (2006) found no difference in cytokine and 
immunoglobulin concentrations in the blood of traumatized humans after 5 days 
treatment with three different concentrations of yeast β-glucan compared to baseline, 
although IgA concentrations were increased in saliva.  
Furthermore, the finding that clinical parameters are improved without a severe elevation 
in concentrations of circulating cytokines and immunoglobulins suggests an immune 
regulatory function of β-glucans that goes further than simply immune activation, as they 
may prime instead of activate leukocytes in vivo to combat invading pathogens. 
β-glucans as prebiotics and their impact on cancer treatment                     
 Pigs fed with oat bran (mainly composed of beta-glucan) showed dramatic dose-
dependent increases in colonic microbial load according to the concentration of the beta-
glucan inside the roll or bran. The highest beta-glucan-content bran induced the highest 
counts in the large intestine from an initial level of about 106/g at the ileo-caecal junction, 
to about 1011/g at the rectum. Increased microbial cell growth leads to an increased 
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binding of nitrogen and its excretion in feces (Knudsen et al. 1991) thus reducing the 
nitrogen load to be excreted via kidneys. Furthermore, besides alleviating the kidney 
burden, the rapid fermentation of soluble fibers in the large intestine by the human 
natural flora, triggers interesting effects on colonic epithelium and colonic cells growth 
and vitality that use the main byproducts (short-chain fatty acids) of beta-gluc n 
fermentation as an energy source. Among the short-chain fatty acids (SCFA) formed, 
butyric acid unmistakably displays the most important effects in the colon. The colonic 
mucosa may use butyrate as a preferential energy source (Roediger et al. 1982), and 
butyrate is almost entirely cleared by the colonic epithelium (Bugaut and Bentejac 1993). 
These acids stimulate cell proliferation in normal colonic epithelium, but retard the 
growth of carcinoma cell lines (Kim et al. 1980).  
Butyrate also has a differentiating effect on isolated cancer cell lines. Butyrate and also 
acetate and propionate (Hague et al. 1995) induce apoptosis (programmed cell death) in 
cultured colonic adenoma and carcinoma cells. The numerous mechanisms of action of 
butyric acid on the colonic epithelium (Scheppach et al. 1998) and at the level of gene 
expression (Smith et al. 1998) have been extensively studied. In addition, beta-glucan 
may have a strong potential regulatory effect on glucose metabolism and insulin action 
(Jenkins et al, 2002). In addition, beta-glucan was shown to lower efficiently LDL 
concentration and the reference dose of a daily intake was 3 % from oat bran (Plotnikoff 







Chromium in glucose and fat metabolism                                                        
 Many studies have shown that this trace element is vital to proper blood sugar control. 
The studies showed that it works closely with insulin in facilitating the uptake of glucose 
into cells. Without chromium, insulin action is blocked and glucose levels are elevated 
(Anderson, 1992; Mooradian et al 1994). In some clinical studies, supplementing the diet 
with chromium has been shown to decrease fasting glucose levels, improve glucose 
tolerance and lower insulin levels and decrease total cholesterol and triglyceride levels 
while increasing HDL-cholesterol levels (Anderson 1992; Mooradian et al 1994). 
Most recently, Vincent and his colleagues had made a major breakthrough regarding the 
structure and role of chromodulin or low-molecular-weight-chromium-binding substance. 
They showed that the oligopeptide, composed of residues of glycine, cystein, glutamate 
and aspartate binds 4 atoms of chromium. The resulting holo form can potentiate 7 times 
the action of insulin without increasing its concentration by binding the insulin receptor-
kinase; and interestingly, insulin stimulation was directly dependent on the number of 
bound chromium atoms (Vincent, 1999; Vincent, 2000).  
Anti-inflammatory effects of chromium                                                          
 Stress due to inflammation is very important among the obese and diabetic patients 
(Hilary Turtle, 2003). Jain and Krishnaswamy demonstrated for the first time that 
chromium chloride inhibited oxidative stress and TNF-alpha in U-937 monocytes (cell 
culture); according to the authors, TNF-alpha was associated with decreased insulin 
sensitivity in vivo in diabetes ( Jain and Krishnaswarmy, 2001). Furthermore, Jain and 
coworkers showed that the reducing effect of inflammation by 17 beta-estradiol vi 
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inhibition of IL-6 secretion was drastically enhanced with the presence of trivalent 
chromium in U937 human monocytes. In addition, the combination (estradiol and 
chromium) was very effective in inhibiting oxidative stress, monocyte adhesion to 
endothelial cells, lipid peroxidation and heart disease risks factors (Jain et al, 2004). 
II.6 Sulfur-containing compounds 
The property of lowering blood sugar has been attributed to onions and garlic (Sheela et 
al 1992). The active principles are believed to be the sulfur containing compounds, allyl 
propyl disulphide (APDS) and diallyl disulphide oxide (allicin), although other 
constituents such as flavonoids may play a role. Experimental and clinical evidence 
suggests that APDS lowers glucose level by competing with insulin (also a sulfur 
containing hormone) for insulin-inactivating sites in the liver (Sharma et al 1977). This 
results in an increase of free insulin. APDS administered in doses of 125 mg/kg to fasting 
humans caused a marked drop in blood glucose levels and an increase in serum insulin. 
Allicin at doses of 100 mg/kg produced similar effects (Sharma et al 1977). In addition 
many hypoglycemic oral drugs are sulfonylureas that are known to lower plasma glucose 
by stimulating insulin secretion and to a lesser extent, by improving peripheral and 








III.1 Animal study 
KK/HIJ mice experiment 
We used an animal model in order to have a better understanding of the mechanisms of 
action of fonio and/or fonio extracted compounds metabolisms in selected living animals. 
Animal Model Used: KK/HIJ Mice. As previously noted, this study aimed to investigate 
diabetes and its complications on an animal model and the the KK/HIJ mice that were 
first produced by Nakamura and coworkers in 1967 (Kanasaki et al 2011).  According to 
them, the " KK/HIJ mice are a very good model of human diabetes. They develop a 
polygenic syndrome of moderate obesity, hyperinsulinemia, hyperglycemia, and 
hyperlipidemia. Like humans with diabetes, they develop renal, retinal, and neurologic 
complications. They also undergo a pre-diabetic stage characterized by mild to oderate 
glomerulosclerosis accompanied by proteinurea. Furthermore, they do not requireeithe  
insulin or other medications for survival, allowing investigators to study how diabetes 
progresses without the inference of drugs (Igel et al. 1998; Reddi and Camerini-Davalos 
1988; Tatlor et al. 1999)." They also mentionned that similarly to the DBA mice, they are 
more prone to develop nephropathy than are four other inbred strains. We also think that 
the renal, retinal, and neurologic complications will result in a production of pro-
inflammatory cytokines as observed in human diabetes.   
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Diet Composition for the KK/HIJ. The diets were prepared by Harlan Laboratory. For 
diets II and III, 30% of fonio and 30% of rice were respectively combined to 70% of 
AIN93 (for whole composition of the diets, refer to annex 3). Vitamins and mineral 
contents but chromium were accounted for and  adjusted as required for the mice diets. 
Mice Methods. A total of sixty K-K/TA mice (3-4 week of age) were used and assigned 
to one of 3 diets during a two-month trial period:  
Group I or control: AIN93 diet (n =20);  
Group II:  AIN93 +Fonio diet (n =20);  
Group III:  AIN93 + rice diet (n =20).  
Mice were fed with the different diets for 49 days and sacrified to investigate 
mechanisms involved in principal tissues (heart, liver, spleen, lungs, and kidney) and 
cytokines assayed following the ELISA method. Mice were anesthetized by CO2 
inhalation for 2-3 minutes until unconscious (not moving but still breathing) and blood 
was drawn from the retro-orbital plexus for the periodical determination of plasma 
glucose and insulin, triglycerides (TGs), LDL and HDL by the Clinical Analyzer. 
Microcultures on liver, lungs and spleen cells were performed for cytokines secretion: 
mitogens at different doses were added to 1 x 106 viable cells in fetal calf serum mdium 
(FCS) and allowed to incubate in a 5% CO2 incubator at 37 degrees Celcius  for 48 
hours, and cytokines were assayed on supernatants using ELISA kits. The whole protocol 
modified by Dr Kuvibidila (personal information) is described in The whole protocol is 
described in Appendix 1. Prior to sacrifice day, insulin activity was assessed by the oral 
glucose tolerance test (OGTT). After a fasting period of 18 hours, mice were fed with 
glucose at dose of 2-g/kg body weight with a gastric gavage at 10:00 a.m. Then 15 
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microliters of blood were extracted from the caudal vein at 0, 30, 60, 120 min at weeks 4, 
6 and 8. Measurements of blood glucose were made immediately using the Clinical 
Analyzer. 
CD1 mice experiment 
These normal healthy mice were used to test the immuno-stimulatory effects of fonio 
extracts. Seven normal healthy male mice, 2 months of age, were provided by the 
Laboratory Animal Resources (LAR) of Oklahoma State University. Early in the morning 
mice were randomly assigned in two groups of 3 and 4. After recording their weights, 
mice were left to accommodate for two hours. After the accommodation period, the 
treatment group (n=3) received by intraperitoneal injection (IP) 10 mg of the fonio 
extract in 100 µl PBS solution and the control group (n=4) received an equal amount of 
PBS solution without fonio extracts by IP injection. Thirty minutes later each group of 
mice received 5 µg of LPS in 100 µl PBS to mimic the septic shock. Two hours after the 
LPS injection, mice were sacrificed. Organs and blood were collected. After 
centrifugation of blood, both plasma and weighed organs were stored at -80ºC. A week 
later, spleen cell suspensions (2 x 106/ml) were activated with 2.5 µg/ml LPS for 48 h. 
Cytokines in plasma and spleen cell supernatants were measured by enzyme 
immunosorbant (ELISA). 
III.2 Cell culture study 
Fonio extract preparation. Extraction of the total beta-glucan from fonio was achieved 
following the method developed by Carr and his colleagues which consists of a 16-hour 
extraction with NaOH = 1N at room temperature followed by its neutralization by HCl= 
1N. The neutralized mixture with a pH of 7.2 was centrifuged and the supernatant rich i 
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beta-glucan, minerals and some proteins were freeze-dried into a brown residue. See the 
diagram of the Carr Method in annex 2.  
Ten mg of the residues composed of total beta-glucan and minerals were dissolve  in 10 
ml of a complete calf serum medium to be used as stock solution. A second stock was 
further obtained through a 1/10th dilution of the first stock solution; solution 2 was used 
for concentrations ranging from of 1 to 5 µg of extract, and solution 1 for concentrations 
in the range of 10 to 100 µg for the treatment of the THP1 cell culture line. 
THP1 Cell Proliferation Methods.The effects of fonio extracts on THP1 Cell 
proliferation and survival was quantified by the colometric method developed by 
Mosmann (1983) and revised by Kuvibidila (1992,1998,and 1999). The method uses a 
tetrazolium salt MTT (3-(4,5- dimethylthiazol-2,5-diphenyl tetrazolium bromide, of 
which the ring can be cleaved within the mitochondria of only living and viable cells 
leading to a chromophore that can be quantified at a wavelenght of 570 or 575 nm. The 
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Digitaria exilis (fonio), a wild cereal consumed in West Africa, is rich in chromium, β-
glucans and sulfur amino acids, factors known to modulate inflammation. Fonio is 
thought to have anti-diabetic properties; however the mechanisms are unknown. We 
hypothesize that it might modulate diabetes pathogenesis through improvement of insulin 
resistance, glucose metabolism, and reduced inflammation. To test our hypothesis, 4-
week old KK/HIJ transgenic male mice were fed either the AIN 93 diet or the sam diet 
fortified with 30% fonio or rice flours (n=20/group). Ten mice per dietary treatm n  were 
sacrificed after either 3 or 4 months of feeding. Glucose and insulin tolerance tests (GTT 
& ITT) were studied by standard techniques 7 days prior to euthanasia. After CO2 
inhalation and prior to euthanasia, blood samples were collected from the retro-orbi al 
plexus, centrifuged at 400 x g and serum was collected and immediately frozen at -80ºC.  
To assess the effects of various dietary treatments on the secretion of inflammatory 
cytokines, 2 x 106/ml viable spleen cells were activated with 2.5 µg/ml of bacterial 
lipopolysaccharides (LPS) or plain medium for baseline for 48 h. Supernatants were 
collected after centrifugation of the cultures at 400 x g, 4ºC, for 10 min, aliquoted and 
frozen at -80ºC until analyzed. Serum and supernatant inflammatory cytokines 
[Interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor–alpha (TNF-
α)] were assayed by enzyme linked immunosorbant (ELISA) with commercial kits. After 
4 months of feeding, results obtained from insulin tolerant test (ITT) were different 
among dietary treatment groups. Although dietary treatment affected feed intake, either 
fonio nor rice significantly affected growth rate. Mean blood glucose levels w re lower in 
mice fed fonio-fortified diet than in those fed the other two diets (p<0.01).  Fonio non-
significantly decreased mean GTT values. Mean serum TNF-α levels were lower in mice 
fed fonio-fortified diet than in those fed baseline and/or rice-fortified diets(p<0.05). 
Mean serum IL-6 levels of mice fed fonio-fortified diet were not different from those fed 
the baseline diet; but they were lower than those fed rice-fortified diet (P<0.006). Fonio 
and rice did not significantly affect in vitro IL-6, TNF-α and IL-10 secretion; however 
IL-1β was significantly reduced in the non-activated spleen cells of the fonio group. Data 
suggest that fonio may modulate diabetes severity by improving insulin tolerance and 
reducing low grade inflammation.  
 
Key words: fonio, type 2 diabetes, KK mice, cytokines, GTT, ITT, inflammation, IL-1, 




Digitaria exilis, mainly known as fonio and confined to West African diets, is currently 
among the promising emerging edible crops in the world, not only because of its taste bu  
mainly due to its alleged potential therapeutic properties. The Agriculture and N tural 
Resources Management Program or Wula Nafaa (WN), a USAID agricultural project is 
completing a trade agreement between fonio producers and the US government, through 
its component referred to as GPFo (Fonio Producers’ Group). For centuries the cereal 
was consumed during ceremonial events and empirically used for diabetes care in West
African countries. The cereal is reported to be different from other cereals b cause of its 
high content of essential sulfur-containing amino acids, specifically methionine and 
cysteine (Sartelet et al 1996; Delumen et al 1993; Becker et al 1986). Apart from the 
important contents of sulfur-containing amino acids confirmed by the study we 
conducted in 2004 (unpublished data), we also found high important amounts of beta-
glucans and chromium. All three components are known to exert beneficial physiologic 
effects on chronic diseases and to boost the immune system through the modulation of 
inflammatory markers (Volman et al. 2007; Keiss et al, 2003; Chang et al, 2010; Brown 
and Gordon, 2003; Burkitt et al 1981).   
Beta-glucans. Beta-gucan is one of the biologically active compounds found in various 
cereals including fonio. Previous studies on beta-glucans revealed that the potency of 
their physiological effects depended on the physico-chemical characteristi s of each type. 
Most studies found in the literature were confined to beta-glucans extracted from oat, 
barley and mushrooms. To date, we are unaware of any studies investigating the effec s 
of fonio beta-glucans on any physiological parameter. 
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Depending on the source, there are clear differences in macromolecular structure between 
β-glucans. The cell wall β-glucans of yeast and fungi consists of 1,3 β-linked 
glycopyranosyl residues with small numbers of 1,6 β-linked branches. In contrast, cereal 
cell walls contain unbranched β-glucans with 1,3 and 1,4 β-linked glycopyranosyl 
residues, whereas β-glucans from bacterial origin are unbranched 1,3 β-linked 
glycopyranosyl residues (Volman  et al. 2007. Furthermore, besides differences in type of 
linkage and branching, β-glucans can vary in solubility, molecular mass, tertiary 
structure, degree of branching, polymer charge and conformation (triple or single helix, 
or random coil). All these characteristics may differently influence several physiological 
parameters. 
As early as 1981, Simpson and his colleagues (1981) showed that these types of fibers 
were capable of slowing the digestion and absorption of carbohydrates, thereby 
preventing rapid rises in blood glucose and increasing the sensitivity of tissue cell  to
insulin and thus preventing an excessive secretion of insulin. Jenkins et al (1980) and 
Vahouny et al (1982) showed that patients who were supplemented with 14 and 26 grams 
of a beta-glucan-rich fiber per day, required less insulin and displayed milder glycosuria. 
In addition, both crude fibers and total dietary fibers were reported to contribute to the 
lowering of the glycemic index of foods (Jenkins et al, 1980; 1981; 2002) and were 
inversely related to body mass index (McKeon et al 2002), HbA1c levels and ketoacidosis 
risk (Toeller 2002). Moreover, fiber consumption reduced urinary C-peptide excretion in 
healthy people as well as circulating insulin and lipids in hyperlipidemic subjects 
(Jenkins et al 2002; Giacco et al 2002). 
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`Brown and Gordon (2003) have recently suggested that high molecular weight β-glucans 
from fungi directly activate leukocytes, while low molecular weight β-glucans only 
modulate the response of cells when they are co-stimulated with pro-inflammatory 
cytokines. With respect to the characteristics of β-glucans, it should also be noted that the 
isolation method may also influence these properties (Volman et al 2007). Due to these 
characteristics, they can behave as different biological ligands for cell re ptors. When 
soluble and non-soluble portions of beta-glucans are administered orally, they are taken 
up by intestinal macrophages for antigen presentation to, and activation of immune cells 
in the spleen, lymph nodes and bone marrow (Hong et al 2004). Once in the bone 
marrow, large molecular weight beta-glucans are reduced into lower molecular weight 
fractions that will bind receptors such as dectin-1 or complement receptor-3 to induce the 
immune responses including cytokines secretion (Hong et al 2004). 
Fiber rich beta-glucan consumption reduced urinary C-peptide excretion in healthy 
people as well as circulating insulin and serum lipids in hyperlipidemic subjects (Jenkins 
et al 2002; Giacco et al 2002). In trauma patients, beta-glucans were shown to induce 
plasma concentrations of IL-1 while they had no effect on those of TNF-alpha (Browder 
et al 1990). However, in contrast to Browder’s study, Lehne et al. (2006) found no 
difference in cytokine and immunoglobulin concentrations in the blood of trauma patients 
after 5 days treatment with three different concentrations of yeast β-glucan compared to 
baseline, although IgA concentrations were increased in saliva.  
Chromium. Currently, it is known that chromium is a vital trace element for glucose 
metabolism. Studies demonstrated that it is a cofactor of insulin that facilitates s action 
in the uptake of glucose into cells. Without chromium, insulin action is blocked and 
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glucose levels are elevated (Anderson 1992; Mooradian et al 1994). Supplementing the 
diet with chromium decreased fasting glucose levels, improved glucose tolerance and 
lowered insulin levels in humans. In addition, total cholesterol and triglyceride levels 
decreased while HDL-cholesterol levels increased (Anderson 1992; Mooradian et al 
1994; Chen et al, 2009). Also, Vincent and his colleagues made a major breakthrough 
regarding the structure and role of chromodulin or low-molecular-weight-chromium-
binding substance. They showed that the oligopeptide, composed of residues of glycine,
cystein, glutamate and aspartate binds 4 atoms of chromium. The resulting holo form can 
potentiate 7 times the action of insulin without increasing its concentration by biding the 
insulin receptor-kinase; and interestingly, insulin stimulation was directly dependent on 
the number of bound chromium atoms (Vincent, 1999; Vincent, 2000). More recently, 
Chen and coworkers showed that chromium supplementation in milk powder improved 
diabetes by enhancing insulin signaling in skeletal muscle through a decrease in IRS1-
Ser307 (Chen et al 2009). 
Jain and Krishnaswamy (2001) demonstrated for the first time that chromium chloride 
inhibited oxidative stress and TNF-alpha in U-937 monocytes (in vitro); according to the 
authors, TNF-alpha was associated with decreased insulin sensitivity (in vivo) in 
diabetes. Furthermore, Jain and his colleagues showed that the reducing effect on 
inflammation by 17-beta-estradiol through inhibition of IL-6 secretion was drastically 
enhanced by the presence of trivalent chromium in U937 human monocytes. In addition, 
the combination (estradiol and chromium) was very effective in inhibiting oxidative 
stress, monocyte adhesion to endothelial cells, lipid peroxidation and heart diseaserisks 
factors (Jain et al, 2004). 
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Sulfur containing amino acids. Fonio is relatively rich in sulfur-containing amino acids 
and some sulfur-containing compounds had anti-diabetic properties. For instance, allyl 
propyl disulphide (APDS) and diallyl disulphide oxide (DADS or allicin), found in garlic 
and onions had the property of lowering blood glucose (Sharma et al, 1977). 
Experimental and clinical evidence suggests that APDS lowers glucose level by 
competing with insulin (a sulfur containing hormone) for insulin-inactivating sites in the 
liver (Sharma et al, 1977). This results in an increase of free insulin. APDS administered 
in doses of 125 mg/kg to fasting humans caused a marked drop in blood glucose levels 
and an increase in serum insulin. Allicin at doses of 100 mg/kg produced similar effects 
(Sharma et al 1977). In addition many hypoglycemic oral drugs are sulfonylureas that are 
known to lower plasma glucose by stimulating insulin secretion and to a lesser extent, by 
improving peripheral and hepatic insulin sensitivity. In a recent study, the oil-soluble 
DADS extracted from garlic were shown to efficiently remove the endotoxin LPS,
reactive oxidants in plasma and to inhibit platelet adhesion (Chang et al, 2010). Also, NF-
κB activity in blood samples treated with unfertilized or sulfur-fertilized garlic extracts 
was reduced by 25%, and 41%, respectively, thus promoting an anti-inflammatory 
environment by cytokine modulation in the surrounding tissues (Keiss et al, 2006). 
There is little, if any information on the effects of fonio on in vivo or in vitro secretion of 
pro-inflammatory cytokines. Inflammation is a common feature of type 2 diabetes and is 
thought to play a crucial role in the disease pathogenesis, either by altering insulin 
sensitivity or by induction of apoptosis of beta cells in the pancreas. We have observed 
that West African patients who regularly consume fonio, experience fewer symptoms 
such as joint pain or weight gain associated with type 2 diabetes. However, neither we, 
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nor other investigators that work in the field of glucose metabolism and type 2 diabetes, 
have ever investigated the mechanism by which fonio modulates these symptoms . In the 
present study, given the high levels of beta-glucan, chromium, and essential sulfur amino 
acids and their properties in improving  glucose metabolism and immuno-regulation, we 
hypothesized that fonio would improve glucose and insulin tolerances, and modulate 
inflammation in diabetic KK/HIJ mice. We defined modulation of inflammation as either 
a decrease in pro-inflammatory cytokines or an increase in anti-inflammatory cytokines 
in the presence or absence of a stimulus. The AIN 93 diet, the AIN-supplemented fonio 
and AIN-supplemented rice diets were used to test their effects on glucose metabolism, 
insulin sensitivity and selected inflammatory cytokines in a mouse model. 
KK/HIJ transgenic mice developed by Nakamura and coworkers in 1967 (Kanasaki et al 
2011) were used to test our hypothesis because they develop a polygenic syndrome of 
moderate obesity, hyperinsulinemia, hyperglycemia, and hyperlipidemia (Nakamura nd 
Yamada 1963; Suto et al 1998; Chen et al 2009), characteristics similar to the human 
disease. Like human diabetic patients, they develop renal, retinal, and neurologic 
complications accompanied by an elevated production of pro-inflammatory cytokines. 
They also undergo a pre-diabetic stage in which they do not require either insulin or other 
medications for survival, allowing investigators to study how diabetes progresses without 
the inference of drugs (Igel et al 1998; Reddi et al 1988).  
Materials and methods 
Samples. Fonio, was obtained in the suburb of Dakar, Senegal, from Maria Distribution 
and the white rice was purchased from a supermarket in  Stillwater, Oklahoma, USA. 
Diet Composition for the KK/HIJ. The diets were prepared by Harlan Laboratory. AIN 93 
(Diet I) was used as control diet. Diet II was obtained by supplementing AIN 93 with 
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30% of fonio and Diet III with a supplementation of 30% rice. Apart from chromium, 
vitamins and mineral contents were accounted for and adjusted as required for the mice 
diets. Chromium contents were left as they naturally occurred in the diets. Table 1 
displays the composition of the AIN 93 G diet and in Table 2 and Table 3, the mineral 
mix and vitamins contents of the AIN G are shown, respectively. 
 










Table 3.  Estimated minimal vitamin and other nutrients composition of AIN-93G 
and 93-M contents.   
 
Fonio analysis. Crude fiber was determined using the Fibertec system E (Tecator) 
consisting of a Hot Extraction Unit 1010 (in which an acidic digestion followed by an 
alkaline digestion were performed), a Cold Extraction Unit 1011 and accessories. Total 
dietary fiber (TDF) was obtained following the enzymatic-gravimetric method by Prosky 
adopted by Association of the American Chemists (AOAC 1984) in combination with the 
Fibertec System E (Tecator). Briefly, the principle is based on the use of th thermo-
resistant alpha amylase (termamyl), protease, and amyloglucosidase as the active 
enzymes. Ground samples are digested with the enzymes followed by a precipitation with 
ethyl alcohol. TDF is calculated as the weight of the precipitates minus the weight of 
undigested protein and ash. Minerals were determined by Atomic Absorption 
Spectrophotometry (by flame with deuterium background correction, or by the graphite 
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furnace AAS with Zeeman background correction) using a AA 5100 (Perkin Elmer, 
Massachusetts, 
USA. The analysis of the amino acids was performed at Langston University using an 
Amino Acid Analyzer (Hitachi L89100 Illinois, USA.  
Experimental animals and diets. Sixty 4-week-old male KK/HIJ mice were purchased 
from Jackson Laboratory, USA. Animal care was in accordance to protocols established 
at Oklahoma State University and approved by the Institutional Animal Care and Use 
Committee. Mice were housed in stainless steel wire cages with woodchip bedding, in 
temperature- and humidity-controlled rooms on a 12-hour light/dark cycle. After 7 days 
of adaptation, mice were randomly separated into 3 dietary treatment groups 
(N=20/group): a. the AIN 93 diet; b. the same diet fortified with 30% fonio flour; or c. 
the same diet fortified with 30% rice flour. Body weights and feed consumption were 
weekly recorded. Fifty percent of mice (n=10) in each dietary treatment group were 
sacrificed after 3 months and 50% after 4 months of feeding 
GTT determination. The test was performed 7 days before sacrifice. Mice were 
transferred into single cages with woodchip bedding and fasted for 8 hours and weighed 
an hour before the test. After an overnight fast, a blood sample (≤ 50 µl) was drawn from 
the tail vein for baseline blood glucose assessment, using a glucometer (One Touch; 
LifeScan, California USA). This was followed by injection of D-glucose (Sigma) into the 
peritoneal cavity. Each mouse received 1 µg glucose /g body weight (1 µg/10 µl water).
Tail blood samples were collected at 10, 20, 30, 60, 90 and 120 min after the injection for 
blood glucose measurements.   
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ITT determination. This test was performed two days before sacrifice. Similarly to the 
GTT, mice were transferred into single cages with woodchip bedding and fasted for four 
hours. They were weighed an hour before the test. Right after fasting, baseline blood 
glucose was determined from blood drawn from the tail vein, using a glucometer (One 
Touch). Then human insulin (humalin) at the dose of 0.75 units/Kg body weight was 
injected intraperitoneally, and blood glucose levels were obtained at 15, 30, 60 and 90 
minutes. 
Spleen cell preparation. Spleens were aseptically removed and immediately transferred 
in pre-weighed sterile culture tubes containing each 1 ml wash medium (RPMI-1640 
supplemented with 25mmol L-glutamine/l 10 g bovine serum albumin/l, 50 mg 
streptomycin/l and 5 X 104 units penicillin/l). After weighing the tubes to estimate spleen 
weights, single cell suspensions were prepared by gently grinding spleens onto a nylon 
mesh filter inserted on top of a sterile 50 ml beaker (the piston of a 3ml syringe was used 
to grind the spleens through the nylon mesh into single cells) as described by Kuvibidila 
et al (1998). The nylon mesh was washed with 10 ml serum-free RPMI-1640 and the 
collected cells were transferred to a 15ml conical centrifuge tube. Tubes wer  centrifuged 
at 1200 rpm, 24ºC for 10 min. The supernatant fractions were decanted and the obtained 
pellets were re-suspended in ice-cold sterile deionized water (1 ml) to lyse and get rid of 
erythrocytes. Further, centrifugation of the tubes was performed twice under the same 
conditions. The pellets were then resuspended in wash medium (2 ml). Total cell count 
and viability were determined using the trypan blue staining technique, and enumeration 
was performed using a hemocytometer under a light microscope.  
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Spleen cell proliferation. Spleen cells proliferation and viability in the presence or 
without E. coli lipopolysaccharide (LPS), were quantified by the colometric method 
(MTT) developed by Mosmann (1983) and revised by Kuvibidila (unpublished) as 
follows:  Viable cells, (2 x 106 per 1000 µl) mixed with or without LPS, were transferred 
in triplicate to each well of a 96-well plate (Corning, NY USA) and plates wereincubated 
at 37ºC, 5% CO2, in a humidified incubator for 68 hours.  Fifty microliters of tetrazolium 
salt (3-(4,5- dimethylthiazol-2,5-diphenyl tetrazolium bromide; 5 mg/ml) were added to 
each well and the plates were further incubated under the same conditions for 4 h. The 
reaction was stopped by adding 50 µl of 0.08 N HCl-isopropanol solution. The test is 
based on the fact that (3-(4,5- dimethylthiazol-2,5-diphenyl tetrazolium bromide, for 
which the ring can be cleaved within the mitochondria only by living and viable cells, 
leads to a chromophore that can be quantified at a wavelenght of 570 or 575 nm. 
Spleen cells culture for in vitro production of cytokines. Spleen cells were cultured at a 
final density of 2 X 106 viable cells/ml in each well of a 24-well Falcon flat-bottom tissue 
culture plate (Corning, NY USA) in RPMI-1640 culturing medium (Sigma Chemical 
Co.) containing 10% FCS and with or without the presence of LPS (2.5 µg/mL, 72 
hours); incubation was allowed to proceed in a CO2 incubator. Cell suspensions were 
centrifuged at 1200 RPM, 24ºC for 10 minutes. Cell free supernatants were stored at 
−80°C for the determination of the proinflammatory cytokines IL-6 and TNF-α. 
Stimulatory Index (SI). After being challenged by LPS, SIs of spleens will be determined 
by calculation. It is obtained by dividing the value of cytokine produced after LPS 
challenge by that obtained before the challenge. 
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Cytokine assays. Cytokine concentrations in the culture supernatants and serum were 
determined by enzyme linked immunosorbant assay (ELISA) utilizing mouse Quantikine 
cytokine kits purchased from R&D Systems (Minneapolis, MN USA). The kit protocols 
were carefully followed.  
Statistical Analysis  SPSS 18 was used and a two-factor between-groups analysis of 
variance (MANOVA) was performed to test differences among groups and to find out 
whether time had an effect. Results  
The concentration of biologically active compounds in fonio is summarized in Table 4.  
Fibers. Fonio was rich in dietary fiber (15.20 %), crude fiber (3.80%) and beta-glucans 
(1.53%). Physiologically, the beta-glucan is the most potent among the 3 types of fibers.  
Sulfur amino acids. The values of methionine (6.8 %) and cysteine (2%) obtained from 
our analysis were in the range of those reported by the National Academy of Sciences 
(4.5 and 2.5% for methionine and cysteine respectively). These variations could derive 
from the fact that there are many species of Digitaria exilis and in addition, the type of 
soil may be another determinant. When we compare our values to other cereals (obtained 
from the National Academy of Science), the total sulfur amino acid of fonio (8.8% from 
our analysis) was more than 3 times higher than those of sorghum (2.6%) and more than 
5 times when compared to maize and was almost ten times higher when it was compared 
to pearl millet. (National Academy of Sciences, 2000).  
Minerals.  Mean concentrations of iron values (8 mg/100 g) found from the National 
Academy of Sciences Report (2000) did not agree with our results (National Academy of 
Sciences, 2000). But they did not precise whether their reported values came from 
dehulled or whole grains. 
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We found 2.4 mg/100 g for the dehulled grains and almost ten times the value in the 
whole grain (22.1 mg/100 g). This may have resulted from the different varieties and/or 
the nature of soils in which the fonio was grown and also the degree of dehulling.  
 
Table 4: Fonio active components 
 
% Fiber % Sulfur amino acids:  Trace elements, µg/g 
(µg/g) 
Crude Fiber:    3.80 Methionine   6.80 Chromium         0.87 
Dietary fiber: 15.12 Cysteine        2.00 Zinc                   25.70 
Fonio beta-glucan:  1.5  Copper               4.00 
Extracts beta-glucan: 60  Iron                    220.81 
 
 
Feed intake and clinical signs. In table 5, clinical changes that occurred in KK/HIJ mice 
during the trial are described. The 4-week old mice had white and normal fur at the start 
of the trial but several changes occurred along with the treatments. These chang s took 
place in two different stages. During the first stage, corresponding to the first 3 weeks of 
treatment, all groups looked normal with no visible physiological changes. Th  second 
stage was characterized by a change of color and other visible signs that occurred in the 
control (AIN) and rice groups. Right after the 3rd week of treatment, KK/HIJ mice in the 
two groups turned yellow, although they conserved normal fur. During the second, third 
and fourth month, fur (AIN and rice groups) not only developed into an intense yellow, 
but in addition  became spiky with a dirty-like aspect. The fonio group was not subject to 
those changes suggesting that supplementation with fonio could block the development 
of the clinical signs observed with the other groups.  
 
Table 5:  Clinical signs of KK/HIJ mice during the trial 
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 Groups Fur   Color  
 AIN93 Fonio Rice AIN93 Fonio Rice 
Week 1-2 Normal Normal Normal White White White 
Month 1 Normal Normal Normal Yellow White Yellow 
Month 2 Normal Normal Normal Yellow White Yellow 
Month 3 Bristling Normal Bristling Yellow White* Yellow 
Month 4 Bristling Normal Bristling Yellow White Yellow 
Final Bristling Bristling Bristling Yellow White Yellow 
In the fonio group, only one mouse (1) developed these characteristics at the 3rd month 
but recovered at the 4th month. These changes were very important since they also 
reflected changes seen in feed intake patterns (Table 5) and probably other important 
physiological changes. 
 
Table 6: Changes in weight gain and feed intakes before and after color change.  
 Before color change  After color change  




   








6.88 ± 0.55 6.47 ± 1.16 6.30 ± 2.35 .95 
 






Values are means ± SEM. *p values reported were obtained after performing paired t tests among the thre 
dietary treatment groups. Means followed by different superscript letters are significantly different; a>b>c; 
p <0.05. 
 
Before the appearance of the yellow color, corresponding to the first stage (first three 
weeks), mean food intakes of all groups were recorded at eight time points, and Paired-T 
Test analyses were performed to test for differences between groups. Feed intake of the 
KK mice in the fonio group was significantly higher than those of the AIN and rice 
groups (P =.000 and P = .003 respectively).  
During the second stage, from about the third week to the end of the trial, when the AIN 
and rice groups turned into a deep yellow with spiky and dirty-looking fur, feed intakes 
for all groups were recorded in 19 time points and paired t-tests were run between groups.  
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The results showed that the feed intake of the fonio group became significantly lower 
than those of the control and rice groups (P = .001 and P = .003) at 125 days of treatment. 
As for body weight gain, neither fonio nor rice affected weight gains (P= 0.21,). 
Relative organ weights.  Results in Table 7 show that there was no significant difference 
between groups (P= 0.095), but there was a trend of higher mean relative liver weights 
(mg/g body weight) of mice fed fonio-fortified diet as compared to the rice g oup (P= 
0.053) at 95 days. However, the fonio treatment reversed that trend at 125 days and 
relative liver weights from the fonio groups were no longer different from the other 
groups (P= 0.73). There was no difference between relative heart weights (mg/g body 
weights) at 95 days (P=.643) or at 125 days (P=0.11), but a trend (Table 3) of lower mean 
relative heart weights of the fonio-fed group was observed at 125 days when compared to 








Table 7: Mean body weights and mean relative organ weights (mg/g body weight).  
 
95 days of feeding     
 Control Fonio Rice *p ≤ 
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N 10 10 10  
Initial Bd Wt (g) 24.99 23.79 24.14  
Final Bd Wt (g) 37.53 ± 1.61 36.95 ± 1.84 36.08 ± 2.98  
Weight gain (g)  12.54 ± 0.69 13.16 ± 0.64 11.94 ± 1.10 0.59 
Liver mg/g Bd Wt 60.20 ±  2.84 66.01 ± 3.79 53.17 ± 4.72 0.095 
Kidneys mg/g Bd Wt 16.34 ± 1.45 15.91± 1.67 15.60 ± 1.19 0.48 
Spleen mg/g Bd Wt 4.41   ±  0.32 3.76 ±  0.21   3.78± 0.28 0.18 
Heart, mg/g Bd Wt 5.39 ± .18 5.33 ± .14 5.55 ± .12 0.64 
Lungs, mg/g Bd Wt 5.94 ±.77 6.31 ±.73 6.28 ±.66 0.67 
     
125 days      
Initial Bd Wt (g) 23.84 24.44 24.34  
Final Bd Wt (g) 38.50 ± 2.40 34.84 ± 2.69 37. 45 ± 2.86   
Weight gain (g)  15.93 ± 0.50 11.06 ± 0.4 13.47± 0.45 0.11 
Liver, mg/g Bd Wt 63.78 ± 3.44 57.77 ±4.01 59.99 ±5.32 0.59 
Kidneys, mg/g Bd Wt 14.78 ± 1.67 15.03 ± .68 15.51± 1.29 0.50 
Spleen, mg/g Bd Wt 4.04 ± 0.26a   3.09 ± 0.10b    3.89 ± 0.19a 0.007 
Heart, mg/g Bd Wt 5.00 ± .0.10 5.03 ± .22 5.47 ± .22 0.11 
Lungs, mg/g Bd Wt  6.28 ±1.19 5.85 ±1.18 5.96 ±1.36 0.64 
 
Values are means ± SEM. P* values reported were obtained after performing MANOVA 
among the three dietary treatment groups. Means followed by different superscript letters 
are significantly different; a>b>c; p <0.05. 
 
Dietary treatments had no significant effects on relative kidney weights at 95 days or 125 
days (P=.482 and P=.497, respectively), but time had an effect on the rice-fed KK groups 
since relative kidney weights at 95 days for all groups were significantly higher than 
those of the KK fed 125 days (P=0.038).  After 95 days of treatment, there was no 
significant difference in relative spleen weights between the 3 groups (P= 0.18). However 
after 125 days of treatment, MANOVA detected significant differences in relative spleen 
weights among the three treatment groups (P= 0.007). Specifically, mean sple weights 
of mice fed fonio-fortified diet were significantly lower than those fed the control or rice-
fortified diets (P = 0.008 and P =0.03 respectively). AIN, fonio and rice supplemented 




Insulin Tolerance Test (ITT). Results in Figure 1 show that at 95 days, there was no 
significant difference between the 3 groups in mean blood glucose levels after the ITT
was performed (P=.441).  
 
 
Figure 1: Glucose levels after ITT at 95 days. 
 
Figure 2: Glucose levels after ITT at 125 days 
 
At 125 days (Figure 2), there was a significant difference in glucose levels between 


























































were significantly lower than those of the control and rice groups (P = .000 and P = .008, 
respectively). 
Glucose tolerance test (GTT).  After 90 days of treatment (Figure 3), none of the three 
treatments affected glucose clearance after GTT was performed (P= .374). 
 
 
Figure 3: Glucose levels after GTT at 95 days 
 
 
























































At 125 days (Figure 4), GTT was still not significant but there was a strong trend of 
lower mean blood glucose levels of the fonio group as compared to the control and rice 
groups (P = 0.057 and P = 0.16, respectively). 
In vitro pro-inflammatory cytokines secretion in KK/HIJ mice. MANOVA (2-Way-
between groups) detected significant differences among the three diets at 95 days in 
spleen secretion of IL-1 beta (P= .003) without LPS challenge. Also, there was a strong 
trend of a lower mean for the fonio group at 125 days of treatment as compared to others 
(P=.067). SI of the rice group was lower than the control and fonio groups at 95 days. 
There was no difference among SIs at 125 days (Table 8).  
Table 8: Effect of dietary treatment on IL-1 beta secretion by spleen cells at 95 and 125 
days. 
 
 Control Fonio Rice *p ≤ 
95 days     
No LPS 10.58 ± 2.43b   10.25 ± 6.33b  18.33 ± 6.4a .003 
With LPS 56.63 ± 5.18 54.24 ± 5.70 64.77 ± 5.6 0.78 
SI 8.01 ± 2.01a    6.18 ±  0.7a    3.76 ± 0.33b 0.07 
     
125 days     
No LPS 9.77  ±  1.50 7.39 ± 0.71 10.99± 1.36 .067 
With LPS 76.98 ± 15.1 53.78 ± 8.62 78.75 ± 19.9 .45 
SI 8.46  ± 1.63  8.28  ±  1.73 6.90 ± 1.20 .74 
Values are means ± SEM. *p values reported were obtained after performing MANOVA among the three 


















Table 9: Effect of dietary treatment on IL-6 secretion by spleen cells. 
 
 Control Fonio Rice *p ≤ 
95 days     
No LPS 30.32 ± 4.49 21.65 ± 11.74 14.03 ± 5.86 .360 
With LPS 468.25 ± 47.2 368.75 ± 93.1 451.60 ± 79.3 .709 
SI 18.97 ± 3.15b 19.06 ± XX b 32.21 ± 5.79a .017 
     
125 days     
No LPS 36.43 ± 6.10 33.34 ± 6.95a 43.70 ± 10.62 .67 
With LPS 380.5 ± 28.6a 263.13 ± 30.4b 475.4± 56.4a .05 
SI 16.78 ± 5.40 12.25 ± 4.56 14.94 ± 2.59 .99 
Values are means ± SEM. *p values reported were obtained after performing MANOVA among the three 
dietary treatment groups. Means followed by different superscript letters are significantly different; a>b>c; 
p <0.05. SIs of the rice is significantly lower than those of the control and fonio groups. 
 
 
Results in Table 9 show that IL-6 levels after LPS activation in spleens from fonio fed 
KK/HIJ mice were significantly lower than those from the control and rice group (P=.05) 
at 125 days. The SI of the rice group was significantly higher than those of the control 
and fonio groups (P=.017) at 95 days. 
 
Table 10: Effect of dietary treatment on TNF-alpha secretion by spleen cells 
 
 Control Fonio Rice *p ≤ 
95 days     
No LPS (pg/ml) 81.30 ± 4.25 82.64 ± 4.31 87.01 ±  8.14 .95 
With LPS 
(pg/ml) 
144.29 ± 13.04 170.90 ± 6.21 191.64 ± 11.61 .23 
SI 1.83 ± 0.20 2.09 ± .060 2.3 1 ± .19 .13 
     
125 days     
No LPS (pg/ml) 81.76 ± 13.76 84.87 ± 10.46 109.22± 27.51 .30 
With LPS 
(pg/ml) 
196.85 ± 31.94 182.87± 19.57 189.65 ± 27.84 .83 
SI 2.64 ± 0.47 2.25 ± 0.23a 2.24 ± 0.39a .69 
Values are means ± SEM. *p values reported were obtained after performing MANOVA among the three 
dietary treatment groups. Means followed by different superscript letters are significantly different; a>b>c; 




The in vitro tests results showed that diets had no effects on TNF-alpha secretion with or 
without LPS challenge at 95 or 125 days (Table 10) 
In vivo pro-inflammatory cytokines secretion in KK/HIJ mice. MANOVA (2-Way-
between groups) results showed that at 95 days (Figure 5), there was no significant 
difference between treatments 
 (P = .713). However, at 125 days (Figure 6) there a significant difference between 
treatments (P = .02); specifically, IL-6 levels in sera of fonio-fed KK/HIJ mice were 
significantly lower than those of rice-fed KK/HIJ mice (P = .006), although there was no 
difference between the fonio group and control groups 
 (P = .233). Mice were not challenged with LPS before their sacrifice. 
 
 
Values are mean ± SEM 

























Values are mean ± SEM, n = 10. Bars with different l tters are significantly different; a>b; p <0.05. 
Figure 6: Serum IL-6 of KK/HIJ mice at 125 days.  
 
Serum TNF-alpha levels. Although there was not a significant difference among groups 
at 95 days (Figure 7), there was a strong trend of lower mean for the fonio group as 
compared to the control and rice groups (P = .08).  However, at 125 days (Figure 8), sera 
TNF-alpha were different among groups (P = .03), specifically TNF- alpha levels of 
fonio-fed KK/HIJ groups were significantly lower than those of the AIN and the rice-fed 





























Values are ± SEM, n=10.   




Values are mean ± SEM, n = 10. Bars with different letters are significantly different; a>b; p 
<0.05. 
































































Spleen cells proliferation. MTT was performed on the spleen cells without and with LPS 
challenge and the percent increase in optical density (OD) was calculated between 
baselines and treated cells as shown in Table 11. Spleen cells of the KK/HIJ diabetic 
mice that were fed fonio-fortified diets for 125 days (Figure 9) proliferated much more 
than those obtained from mice fed the control and rice-fortified diets  
(P = 0.04).There was no significant difference in percent increase at 95 days, however a 
strong trend of higher mean percent of fonio-fed group was observed (P = 0.053).  
Table 11: Spleen cells proliferation by the MTT test.  
 
 Control Fonio Rice *p 
95 days 13.63 ±8.81 16.28 ± 6.50 15.42 ± 8.23 0.053 
125 days 12.71 ± 5.20b 45.19± 11.42a 11.58 ± 3.94b 0.04 
Means followed by different superscript letters are significantly different; a>b>c; *p <0. 
And interestingly, their activity was better controlled after being challenged with LPS. 
With a higher proliferation rate, they moderately produced quantities of proinflammatory 
cytokines (IL-6 and TNF-alpha), whereas the rice and fonio groups with a lower 
proliferation rate, produced too much cytokines in a non-controlled fashion after the 
challenge insomuch as there was no significant difference in the stimulatory indexes 





Bars with different letters are significantly different; a>b>c; p <0.05.  
 
Figure 9: Spleen cells percent increase in proliferation before and after LPS challenge.  
 
Discussion 
The aim of the present study was to investigate the effects of fonio and rice on diabetes 
pathogenesis in KK/HIJ mice. A first group of ten mice from each group was sacrificed at 
3 months and the remaining at 4 months of treatment. Overall, results indicated that fonio 
reduced several aspects of diabetes and obesity-related complications. The fonio-f d 
group displayed different eating patterns, as well as different GTT, ITT and cytokine 
profiles. All of these factors do contribute to the pathogenesis of diabetes. Important 
pathological changes were observed with time accompanied by physiological changes 
that occurred in the control and rice groups and which did not affect the fonio group. 
Those changes occurred at two specific stages during the treatment period. In the first 3 
weeks of feeding, all 3 groups looked normal without any color change or other signs 






























modified nature of being bound to growing into obese mice. However, it was interesting 
to note that in this stage, feed intakes of the baseline diet-fed (control) and rice-fed 
groups were significantly lower than the intakes of the fonio group feed (P = 0.000 and 
0.003, respectively)  
The second stage, after the first 3 weeks to the end of the trial, was characterized by the 
reversed trend in the eating patterns; the rice group was eating more than the fonio group 
(P = 0.001) and the AIN group with a higher mean feed intake was eating at least as 
much as much the fonio group did (P = 0.003). This sudden hyperphagia, noted in the 
rice and control groups, may be due to the fact that the KK/HIJ mice are obtained by 
transferring the obese agouti allele to the inbred KK mice and the latter are bound to 
develop hyperphagia caused by the development of a strong leptin resistance whe they 
become obese (Iwatsuka  et al 1970). The same eating pattern was observed in humans in 
a study in which obese subjects were shown to eat more than the normal (Guss et al 
2002)  
In addition, this inversed trend in the eating pattern was accompanied by a change in 
coloration of the mice; the fur of the hyperphagic groups (rice and AIN) gradually turned 
into a faint yellow color characteristic of the KK/HIJ mice when obesity i  present. In 
fact, the agouti gene encodes a 131-amino acid protein containing a signal sequence 
which is produced in the hair follicule playing the role of a strong antagonist to the
melanocyte stimulating hormone (MSH) receptors located on melanocytes. Thus the 
hindrance to the melanocytes receptors would inhibit the production of the α-MSH 
eumelanin that is responsible for the yellow coloration of the fur (Breyer et al 2005). The 
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observed changes cited above were exacerbated in the control and rice groups at the end 
of the trial. 
Analysis of the food intake in the KK/HIJ mice showed that nutrition therapy usingfonio 
cereal may at least temporarily block the expression of the obese agouti gene in KK mice 
through a significant decrease in food intake, not accompanied by a significant weigh
loss.  Only one mouse from the fonio group expressed the yellow color but recovered the 
following month. That mouse showed signs of sickness throughout the trial. The food 
intake at the 4th month of the control and rice groups drastically increased corresponding 
to the strongest yellow coloration of their furs.  
Cytokines are known to be physiologically beneficial in trace amounts and can be 
detrimental to the host if they are over or under expressed in certain cases (Munoz et al 
1995). Particularly in diabetes mellitus, presence of low-grade pro-inflammatory 
cytokines may lead to the aggravation of the disease and later to death if the condition is 
uncontrolled (Grimble 2005). In that regard, supplementing the diet with fonio 
peripherally reduced serum-circulating pro-inflammatory cytokines (TNF-alpha and IL-
6). After 125 days of treatment, serum IL-6 in the fonio-fed KK group was lower than the 
rice group (P = 0.006) but was not statistically different from the control (AIN) despite 
displaying a lower mean. Similarly, at 125 days, serum TNF-alpha levels in the fonio-fed 
group were significantly reduced when compared to the control (P =0.01) and rice (P 
=0.05) groups. Because high blood levels of TNF-alpha have  been shown to induce 
insulin resistance in diabetes (Jain and Krishnaswamy 2001), we speculated that the
lower concentration of TNF-alpha in mice fed fonio-fortified diet, may at leasexplain in 
part the observed improved insulin resistance as shown by the ITT results. After the 125-
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day feeding period, when ITT was performed, the areas under the curves for mice fed 
fonio-fortified diet were significantly lower than those fed the control and rice-fortified 
diets (P = 0.000 and P = .008, respectively). The presence of high levels of chromium in 
fonio may further explain the decrease in TNF- alpha production since the same authors 
(Jain and Krishnaswamy, 2001) demonstrated for the first time that chromium chloride 
inhibited oxidative stress and TNF-alpha in human U-937 monocytes and that the 
reducing effect of inflammation by 17 beta-estradiol through inhibition of IL-6 secretion 
was drastically enhanced by the presence of trivalent chromium in U937 human 
monocytes.   
Thus, in the present study, the mechanisms of action may be attributed to the presence of 
the above cited active compounds in the cereal; beta-glucans, chromium for its 
stimulatory effects on the immune system and to a lesser extent the sulfur amino acids 
that contribute to glucose and insulin metabolism. (Sheela et al 1992). Certain  sulfur 
containing compounds such as allyl propyl disulphide (APDS) and diallyl disulphide 
oxide (allicin) lower glucose levels by competing with insulin (a sulfur containing 
hormone) for insulin-inactivating sites in the liver (Sharma et al 1977), leading to a lesser 
loss of endogenous insulin, resulting in a lower production of the hormone by the body.  
Although mean spleen weights of mice fed fonio-fortified diet were significatly lower 
than those of the mice fed the control diet (P = 0.02) and tended to be lower than those 
from mice fed the rice-fortified diet , MTT results showed that spleens from the fonio 
group proliferated more than the control and rice groups after LPS challenge. The higher 
mean weights of spleens from mice fed the control and rice-fortified diets may uggest an 
early activation due to the presence of elevated circulating serum pro-inflammatory 
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cytokines. This phenomenon is usually observed in diabetic and obese mice. Santos and 
his colleagues showed that spleen weights in gnotobiotic mice increased after infection 
was induced (Santos et al 2007). At baseline (without LPS stimulation), spleen cells of 
the fonio group were less activated and expressed less TNF-alpha, IL-6 and IL-1 beta 
confirming the trend observed in the sera. High circulating levels of IL-1 beta that re 
common in diabetic subjects were significantly reduced in vitro in the fonio group at 90 
days (P= 0.003) and an excellent downward trend was observed at 125 days (P= 0.067).   
It is probable that the presence of high serum concentrations of pro-inflammatory 
cytokines at baseline in the control and rice groups may have already activated heir 
spleens in vivo. Not only are they active blood filters in helping get rid of certain foreign 
bodies from the peripheral circulation, spleens also play an active role against 
inflammation and infection. This activation generally leads to a higher recruitment and 
priming of more splenocytes that may have resulted in heavier spleens in the control and 
rice groups. As a result they presented more splenocytes in vivo but the latter were more 
exhausted than those from the fonio group that proliferated better when challenged in 
vitro because of being less primed by a lower quantity of peripheral low-grade 
inflammatory cytokines.  Interestingly, spleens cells of the fonio group that proliferated 
more, secreted moderate amounts of  IL-6 and TNF-α and IL-1 beta after LPS challenge. 
Because of their important rate of proliferation, stimulatory indexes from the fonio group 
were expected to yield higher SIs, but that was not the case since there was no difference 
in SIs among groups suggesting that spleens cells of the rice and fonio groups had to 
express more cytokines per unit cell in order to match SIs from the fonio group. 
According to Grimble (2008), in certain conditions such as infection and chronic 
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inflammatory diseases, the host is activated by producing compounds such as cytokines 
or other chemicals such as nitric oxide and acute proteins. And when the condition is 
resolved, the body shifts to an inactivation mode which is followed by the clearance of 
these cytokines or toxic compounds. But a problem with chronic diseases such as 
diabetes, is that the body fails to fully remove those circulating cytokines. As a result, the 
body is left with high levels of low grade cytokines that can be detrimental, leading to 
death in some cases (Grimble, 2008). It is not clear but it looks like that under 
inflammatory conditions, immune cells of such chronic disease patients overreact by 
secreting too much cytokines in an uncontrolled manner which makes it difficult for their 
bodies to completely clear those cytokines even when the condition abates.  
Conclusion 
In summary, the following are the new findings of the current study: 
a. After 4 months of dietary treatment, results showed that supplementation of the 
diet with 30% fonio can improve insulin resistance and glucose tolerance. 
b. 30% of fonio supplementation  reduced food intake in KK/HIJ diabetic mice.  
c. Supplementing the KK/HIJ mice with 30% fonio blocked the development of 
their yellow color characteristic of obesity. Therefore, we can inferthat fonio may 
play a role against obesity by blocking the expression of an obese gene.  
d. Fonio tended to decrease plasma levels of  IL-6, but not TNF-α. Decreased IL-6 
will modulate blood levels of C-reactive protein, a marker of inflammation and 




e. Compared to rice, fonio also tended to decrease in vitro secretion of IL-1β and IL-
6, but not TNF-α by LPS activated spleen cells. IL-1β is known to induce 
apoptosis in cells of islets of Langerhans.  
f. Limitations of our study included:  
a. Mice were received by groups of ten over a period of 2 months leading us to 
slightly modify our design.  
b. Although we had 3 groups of 20/diet, we further subdivided them in two sub-
groups to test the effects of short versus longer exposure to the diets. Therefore 
some tests (like GTT) lacked adequate statistical power. 
c. Important tests such as quantification of the obese gene after treatment would be 
important but funding was not available for these tests.   
 
In conclusion data suggest that fonio may modulate severity of diabetes by reducing 
inflammatory cytokines and increasing insulin sensitivity. And very importantly, fonio 
may play an important role against the onset of obesity. 
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CHAPTER V: ARTICLE II 
 
 
FONIO EXTRACTS CAN MODULATE IN VITRO INFLAMMATORY 
RESPONSE IN NORMAL CD1 MICE AND THP1 CELLS 
 
Abstract 
Background: We recently investigated the effects of fonio-supplemented dit on the pathogenesis 
of diabetes and inflammation in diabetic KK/HIJ mice. Fonio-supplemented diet was found to 
modulate inflammatory cytokines and improved diabetes parameters in the mice. The goal of the 
present study was twofold: a) to investigate the immunostimulatory effects of fonio extracts in 
non-diabetic healthy CDI mice; and b) tp determine the mechanisms by which fonio extracts 
modulate cytokine secretion in monocytic THP1 cell line. 
Methods: (1) Non-diabetic healthy CD1 mice received an injection in the peritoneal cavity of 
bacterial lipopolysaccharides (LPS) followed by fonio extracts (mostly composed of beta-glucan) 
and then were sacrificed 2 h later. Spleen cell suspensions (2 x 106/ml) were activated with 2.5 
µg/ml LPS for 48 h. 
(2) Monocytic THP1 cells were incubated without and with different concentrations of fonio 
extracts for 24-72 h. Cell proliferation, viability and differentiation were assessed by trypan blue 
exclusion, nitroblue tetrazolium salt reduction methods, and microscopy, respectively. Cytokines 
in plasma and spleen cell and THP1 supernatants were measured by enzyme immunosorbant 
(ELISA). 
Findings and Conclusions: (1) Fonio extracts significantly up-regulated the secretion of TNF-α 
(pro-inflammatory cytokine) and IL-6 secretion (immune-modulatory – pro- and anti-
inflammatory cytokine) in vivo (plasma) and in vitro (supernatant) in LPS-treated CD1 mice.  
(2) Fonio extracts reduced monocytic THP1 cell growth via differentiation nd not necrosis. This 
is the first study showing that fonio can produce immunostimulatory effects in non-diabetic mice 
and induce cell differentiation of a cell line. The current data allow us to conduct a translational 
human study.  
Key words: CD1 mice, THP1 cell line, inflammation, pro and inflammatory cytokines, c ll 
proliferation, cell differentiation. 
 
1. Introduction 
Digitaria exilis, mainly known as fonio and confined to West Africa, is currently among 
the promising emerging edible crops in the world, not only because of its taste but also 
due to its alleged potential therapeutic properties. The cereal that has been used for 
diabetes care in West African countries for centuries (personal communicatio ) is 
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reported to be different from other cereals because of its higher contents in essential 
amino acids such as methionine, cysteine (sulfur-containing amino acids) leucine, and 
lysine. Its amino acid profile, compared to that of whole-egg protein, showed that excep
for the low score for lysine 46%, the other scores were high: 72% for isoleucine; almost
100% for valine, tryptophan, threonine and phenylalanine; 127% for leucine; 175% for 
total sulfur and 189% for methionine (Delumen et al 1993; Delumen et al 1986). In 
addition, our study in 2004 (Table 1) showed that fonio contained substantial amounts of 
beta-glucan, chromium, iron and zinc: compounds known to exert beneficial physiologic 
effects on chronic diseases (Traore et al 2004) and to boost the immune system through 
the modulation of inflammatory markers (Volman et al 2007; Brown and Gordon  2003; 
Burkitt et al 1981). Previous studies on beta-glucans from oat, barley and mushrooms 
showed significant differences in their physiological effects, depending on their intrinsic 
characteristics (Brown and Gordon 2003; Hong et al 2004; Jenkins et al 2002).  Up-to-
date, there is a paucity of data on the effects of fonio extracts (rich in beta-glucan) on 
inflammatory cytokines.  
Depending on the source, there are clear differences in macromolecular structure between 
β-glucans due to the type of linkages, branching, molecular mass, tertiary structure and 
isolation methods (Volman et al 2007). These characteristics may influence their immune 
modulating effects. For example, Brown and Gordon (2003) have r cently suggested that 
high molecular weight (MW) and/or particulate β-glucans from fungi directly activate 
leukocytes, while low MW β-glucans from fungi only modulate the response of cells 
when they are stimulated with cytokines. Due to these differences they behave as 
different biological ligands for cell receptor proteins. Currently, research has 
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demonstrated that both soluble and non-soluble portions of beta-glucans, orally 
administered can be taken up by the intestinal macrophages by phagocytosis to be 
conveyed to the spleen, lymph nodes and bone marrow. Once in the bone marrow, large 
molecular weight beta-glucans are reduced into lower molecular weight fractions that 
will bind to dectin-1 receptors or complement receptor-3 to modulate inflammatory 
cytokines and/or other immune responses (Hong et al 2004). 
It is also known that people with diabetes experience a pro-inflammatory cytokines 
burden (referred to as low grade cytokines) that exposes them to a higher morbidity and 
mortality when compared to non-diabetic subjects (Tuttle et al 2004). Danzer (2001) 
reported that peripherally released cytokines (IL-1 and TNF-α) were not only responsible 
for local inflammatory responses, but also, they synchronize the physiological and 
behavioral components of the systemic acute phase response to infection.  
Our recent in vivo study (manuscript under-preparation) that investigated the effects of 
fonio on diabetic KK/HIJ mice in a 3 or 4 month period showed that the wild cereal was 
capable of reducing low grade inflammatory cytokines that are known to be high in 
obesity and diabetes and which can be detrimental to the host. But the positive results 
obtained in that study were mainly observed in the 4-month treated mice. The 3-month 
treatment was not as effective as the 4-month, probably due to a lower exposure to the 
treatment. In this present study, we wanted to know whether fonio could help during 
infection/inflammation for many studies showed that infection was a problem among 
people with diabetes (Davies et al 2005; Cardoso and Salles 2007; Shakov et al 2011) 
Therefore we decided to run a pilot study whose objective was to treat LPS-challenged 
CD1 mice with concentrated extracts of fonio to investigate whether:  
88 
 
The CD1 mice treated with the extracts would positively react against the induced 
inflammation by producing enough pro-inflammatory cytokines to defend themselves.  
We hypothesized that the fonio extracts treated mice would respond positively; therefore 
we designed another experiment to investigate: 
• The mechanisms by which fonio reduces the secretion of the inflammatory 
cytokines when inflammation is not present 
• The mechanisms by which fonio increases the inflammatory cytokines if 
inflammation is induced.   
For that purpose, an in vitro design is the ideal protocol since it allows assessment of 
outcomes without the confounders brought about by the various physiological events 
taking place in vivo.  
THP1 cells were used for that purpose. This monocytic cancer cell line was challenged 
with LPS (simulation of inflammation) and treated with the fonio extract to test its 
capacity of modulating inflammation by reducing the proliferation rate of cells and 
cytokine release. Also the mechanisms involved in the process were investigated. THP1 
cells are a suitable model for the study because after challenge, they can produce several 
types of cytokines such as IL-1, IL-6, IL-8 and TNF-α  (Samantha et al, 2006),  Haversen 
et al, 2001).  
Three objectives were set for the study: 
 a. THP1 cells with or without fonio were treated with the extracts in the presence of LPS 
and the 3-(4,5- dimethylthiazol-2,5-diphenyl tetrazolium bromide method (MTT) was run 
to test the effects of the extracts on the viability and proliferation rate; 
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 b. the Dye Exclusion method was performed on the suspended cells to determine if 
proliferation rate was decreased by apoptosis or necrosis and;  
c. Nitroblue tetrazolium test (NBT) was performed to determine whether or not the 
decreased growth rate was due to cell cycle arrest induced by differentation. 
If fonio extracts could modulate the production of the above cited cytokines in both CD1 
mice and THP1 cells, then we would probably have a first evidence that fonio might help 
in diabetes care by inducing immuno-stimulatory effects and/or attenuating inflammatory 
markers.  
2. Materials and Methods 
3.1 THP1 cell culture line and CD1 mice.THP1 cell line was obtained from the American 
Type Culture Collection, Rockville, MD, USA and CD1 mice were provided by the 
Laboratory Animal Resources (LAR) of Oklahoma State University.  
2.2 Fonio cereal. Fonio was purchased at Maria Production, one of the biggest suppliers 
in Dakar, Senegal. 
2.3 Chemicals. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) 
was purchased from Sigma Chemicals (St Louis, MO).  
2.4 Fonio extracts preparation and β-glucan determination. Extraction of total beta-
glucans from fonio was achieved following a modified method developed by Carr and 
colleagues (Carr et al 1990) consisting of a 16-hour extraction of of whole fonio flour 
with NaOH (2g fonio/1ml NaOH) at room temperature followed by its neutralization in 
HCl. The neutralized mixture with a pH of 7.2 was centrifuged (1000 rpm) and the 
supernatant rich in beta-glucan s was freeze-dried into a gray residue (figur 1). Beta-
glucan concentration in fonio extract was determined using Megazyme kits (Megazyme 
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International Ireland Ltd, Bray Business Park, Bray, Co Wicklow, Ireland) nd a 1µg/µl 
solution from fonio extract was prepared and kept at -20 ºC for further use. 
 Table 1: Fonio active components 
 
% Fiber % Sulfur amino acids:  Trace elements, µg/g 
(µg/g) 
Crude Fiber:    3.80 Methionine   6.80 Chromium         0.87 
Dietary fiber: 15.12 Cysteine        2.00 Zinc                   25.70 
Fonio beta-glucan:  1.5  Copper               4.00 




Figure 1: Beta-glucan extraction (This diagram is from Carr et al. 1990). 
 
2.5 CD1 mice. Seven normal healthy male mice, 2 months of age, were provided by 
LAR. Early in the morning mice were randomly assigned in two groups of 3 and 4. After 
recording their weights, mice were left to accommodate for two hours. After the 
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accommodation period, the treatment group (n=3) received by intraperitoneal injection 
(IP) 10 mg of the fonio extract in PBS solution and the control group (n=4) received an 
equal amount of PBS solution without fonio extracts by IP injection. Thirty minutes later 
the mice received 5 µg of LPS to mimic the septic shock. Two hours after the LPS 
injection, mice were sacrificed and organs and blood were collected. Blood was 
centrifuged, then both serum and weighed organs were stored at -80ºC until analyzed. 
2.6 CD1 spleen cells. Spleen cells preparation and proliferation were performed 
following the method by Mossman (1983) and slightly modified by Kuvibidila et al 
(1992; 1998; 1999). 
2.7 Cytokine assays on serum and spleen supernants of CD1 mice. Cytokine 
concentrations in the culture supernatants and serum were determined by enzymeli ked 
immunosorbant assay (ELISA) utilizing mouse Quantikine cytokine kits purchased from 
R&D Systems (Minneapolis, MN USA). The kit protocols were carefully followed.  
3.8 THP1 Cell growth and count. Prior to the microculture (MTT) and macroculture 
(mitogen-fonio-dose response) tests, THP1 cells were allowed to grow in 10% fetal 
bovine serum under an atmosphere of 5% carbon dioxide at 37 ºC for a for a period of 7 
to 8 days; the medium was changed every 72 h in order to grow enough cells to use for 
the tests.          
 The Dye Exclusion method was performed on the suspended cells to determine the 
viability of THP1 cells that were treated with fonio extracts. For that purpose, 10 µL of 
the obtained cell suspension and 90 µL of 0.4% trypan blue were transfered into a 1ml 
Eppendorf tube, and injected into the well of a haemocytometer. Living cells (clear) that 
excluded the Trypan blue were counted against dead cells (blue) that didn’t. Viability of 
92 
 
cells was calculated as a percentage of the living cells over the total count of cells (alive 
+ dead). The viability of cells used for the microculture and macroculture tests wa  
between 85 and 95%.   
2.9 Effect of fonio-dose response. Following the method developed by Mossman and 
slightly modified by Kuvibidila et al (1992; 1998; 1998) colorimetric 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide test (MTT) was performed on the 
suspended THP1 cells. An aliquot containing 106 THP1 cells was transferred into each of 
six 15-ml tubes. Then 0, 2.5, 5, 10, 50 and 100 µg/ml of fonio extracts dissolved in fetal 
bovine serum were respectively added in the six tubes and completed to 1ml with 10% 
fetal bovine serum. From each tube, 3 replicates of 200 µl were transferred into the wells 
of a 96-well plate.  The plate was incubated under an atmosphere of 5% carbon dioxide at 
37 ºC for 68 hours, and 50 µl MTT solution was added in each wells and the incubation 
period was allowed to proceed for an additional 4 hrs for a total of 72 hours. MTT 
reaction was stopped by adding 50 µL isopropanol-HCL solution to each well. The 
optical density (OD) was read at 570 nm with a reference wavelength of 650 nm. Mean 
ODs of triplicates were obtained to calculate the ratio of OD over the baseline (culture 
without fonio extracts). 
2.10 Effects of fonio on IL-8 and IL-6 secretion by THP1 cells (macroculture). Prior to 
running the macroculture, several essays (data not shown) were made to find out an 
adequate concentration of LPS that would induce the secretion of subsequent amounts of 
cytokines by THP1 cells. A concentration of 2.5 µg per ml of culture containing 2x106
cells yielded very good results.             
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 For the IL-8 experiment, 2 x106 of viable cells were transferred to each well of three 24-
well plates, following a chart including all six levels of treatment: HP1 cell alone; THP1 
+ 2.5 µg LPS; THP1+ 2.5 µg fonio; THP1+ 5 µg fonio;  THP1+ 2.5 µg fonio + 2.5 µg 
LPS;  THP1 + 5 µg fonio+ 2.5 µg LPS. For the IL-6 experiment, concentrations of 1, 2.5, 
5, and 10 µg fonio were used. Each well was brought to a volume of 1 ml with 10% fetal 
bovine serum. Then, plates were placed in a CO2 incubator set at 37 ºC, 5% CO2 in a 
humidified atmosphere. The concentration                                                                                                             
After 24 hours of incubation, the first plate was centrifuged at 1000 rpm, 4 ºC, for 10 
minutes and supernatants (around 500 µl) from each well were collected in 1.5-ml 
Eppendorf vials and stored at -80 ºC until cytokines essays. The same procedure was 
repeated for the second and third plates at 48 hours and 72 hours of incubation, 
respectively. Cytokines were further assayed by ELISA method. 
2.11Combined Dye Exclusion and NBT tests. We wanted to know the mechanisms 
by which fonio extracts were slowing the proliferation of THP1 cells evidenced by the 
MTT test. For that purpose, THP1 cells allow to grow in Roswell Park Memorial Institute 
medium (RPMI) medium for 5 days at 37ºC. Then the viability of the cells was 
determined with the dye exclusion method as described in 2.6.  THP1 cells with viability 
between 85 and 95% were incubated with fonio at different concentrations for in a 24-
well plate. After 72 hours of incubation cells were recounted to determine their new 
viability. If the viability before and after treatment were the same, it would be concluded 
that the extracts did not induce apoptosis. Also, NBT test would be performed to 




Briefly to run the NBT test, THP1 cells were incubated for 5 days with or without fonio. 
On the 5th day Cells were pelleted and re-suspended in a RPMI-1640 solution of NBT 
and incubated for an hour at 37ºC. Then cell were re-pelleted and dissolved in Dimethyl 
sulfoxide (DMSO). Optical densities were read at 540 nm. 
Table 2: NBT chart for THP1 cells treated with different fonio extracts. 
 1 2 3 4 5 6 
A 0 µg Fonio  
+THP1 
0 µg Fonio  
+THP1 
+ Vit D 
0 µg Fonio  
+THP1 
+ RA 




 + RA 
+THP1 
Vit D + RA  
+ THP1  
+ 2.5µg 
Fonio 
B 2.5µg Fonio  
+THP1 
2.5µg Fonio  
+THP1 
+ Vit D 
2.5µg Fonio  
+THP1 
+ RA 






Vit D + PMA 
+THP1+ 
2.5µg Fonio 
C 5 µg Fonio  
+THP1 
5 µg Fonio  
+THP1 
+ Vit D 
5 µg Fonio  
+THP1 
+ RA 
5 µg Fonio  
+THP1 
+ PMA 
Vit D  
+ LPS 
+THP1 
Vit D + LPS 
+ THP1+ 
2.5µg Fonio 
D 10 µg Fonio  
+THP1 
10 µg Fonio  
+THP1 
+ Vit D 
10µg Fonio   
+THP1 
+ RA 
10µg Fonio   
+THP1 
+ PMA 
Vit D  
+ RA  
+ PMA 
+THP1 
Vit D + RA 




NB. NBT was not performed for all wells of the above experiment that was repeated 4 
times, due to lack of NBT reagents (lack of funding). But all images of the THP1 cells 
during the experiment were taken and saved.  
Statistical Analysis:  SPSS version 18 was used for the analysis. A One-Way ANOVA 
between groups was performed followed by Turkey’s Multiple Comparison. 
3. Results 
3.1 Beta-glucan extraction.The modified Carr method (1990) used for extraction of beta-
glucan from fonio flour yielded a good concentration after freeze-drying (60%). Fonio, 
alike many cereals has a low lipid content [3]. Therefore, the treatment with ethanol 
(refluxing) in order to defat high fat samples before the alkaline extraction of beta-glucan, 
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was unnecessary. Two types of extracts were obtained after neutralizing with 
hydrochloride acid; a brown fraction with a pH of 7.4 and a gray fraction with a pH of 7.2 
that was used for the micro and macroculture of the THP1 cells (closest to neutral pH 7). 
3.2 Summary of data obtained from CD1 study.Table 3 summaries data obtained from 
the CD1 pilot study. Apart from the body weights, there were significant differenc s 
between all measured parameters. The mice treated with fonio extracts produced higher 
levels of the inflammatory cytokines in vivo (serum) or in vitro (spleens) tests. Spleen 
weights of the treatment group were also higher than those of the control group.   
 
Table 3: CD1 mice body, spleen weights and selected cytokines production. 
 CD1 ctrl CD1 Fonio Trt *p ≤ 
Body weight (g) 21.26  ± .55 21.74 ±0.39 .497 
Rel. Spleen weight 
(mg/g)BW 
4.46 ± .394b 6.53  ± .240a .001 
Spleen MTT (OD) 0.333 ± .0391b 
 
0.345 ± .0073a 
 
0.04 
Spleen TNF-α (pg) 15.67 ± 2.45b 269.20 ± 38.18a 0.02 
Spleen IL-6 (pg) 18.47 ± 10.57b 136.09 ±  20.13a .002 
Serum TNF-α (pg) 31.75 ± 19.96b 909.56 ± 53.58a .000 
Serum IL-6 (pg) 23.85 ± 5.43b 638.43 ± 122.56a 0.037 
Values are mean ±  SEM. Means in rows followed by different superscript letters are significantly different; 
a>b; p <0.05.  
 
 
3.3 Cell proliferation and viability assessed by the MTT Test. In Figure 2, the MTT 
results showed that all concentrations of the fonio extracts significantly reduced the 
proliferation of THP1 cells as compared to the baseline. These results were obtain d from 




Figure1. Fonio effects on THP1 growth 
 
Bars with different letters are significantly different; a>b>c; p <0.05. 
Figure 2: MTT results from THP1 incubated with different fonio extracts concentrations. 
 
In figure 2, fonio extracts significantly decreased THP1 cells proliferation in a dose 
dependent manner from concentrations between 1 and 5µg, but concentrations of 5 and 
10 µg were not different as well as concentrations of 25 and 100 µg. Therefore, only 
concentrations of 2.5 and 5 µg of extracts were used for the macroculture to test for their
effects on inflammatory cytokines. 
3.4 IL-8 and IL-6 production of THP1 treated by the combination of LPS and fonio 
extracts 
 Figure 3 shows that challenging cells with LPS resulted in elevated amounts of IL-8 
secreted by THP1cells without fonio extracts (6028, 5579 and 4693 pg) during all three 
time points (24, 48, and 72 hrs, respectively). However, the different treatments with 2.5 
and 5 µg of fonio extracts significantly reduced IL-8 expression in a timely dependent 
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Bars with different letters are significantly different; a>b>c; p <0.05. 
Figure 3: IL-8 production of THP1 cells treated with LPS and fonio extracts.                         
 
 
Bars with different letters are significantly different; a>b>c; p <0.05. 




































































































































































































































































































IL-6 values for THP1 alone with or without fonio were practically undetectable. Aft r 
being challenged with 2.5 µg LPS and treated with different concentrations of fonio (1; 
2.5; 5; and 10 µg), results showed that there were high levels of IL-6 produced by THP1 
cells treated with LPS (Mean = 740 Pg) that significantly decreased (P =0.0001) across 
the set time points of 24, 48, and 72 hours (Figure 4).  However, LPS challenged THP1 
cells treated with 1, 2.5 and 5µg of fonio extracts, produced significantly higher levels of 
IL-6 than those treated with LPS alone at 24 hours (P= 0.0001, 0.047, 0.001, 
respectively); after 48 and 72 hours, they were no longer different. There was no 
difference between LPS challenged THP1cells and those treated with LPS and 10 µg 
fonio extracts at any time period. Compared to IL-8 results, opposite effects wre 
obtained with IL-6 secretions after LPS challenge. It is interesting to note that the lowest 
fonio concentration (1µg) yielded the highest levels of IL-6, although not significantly 
different to 2.5 or 5 µg. 
3.5 Dye exclusion and NBT testing for cell apoptosis or proliferation. We conducted the 
dye exclusion test to determine whether fonio extracts exerted cytotoxic effects on THP1 
cells to retard or stop growth. Results showed in Table 4 show that cells conserved their 
viability. We used cell viability of 85% and above for all our experiments. Therefor , we 








Table 4: Viability of THP1cells treated with fonio extracts using the dye exclusion test. 
Fonio extracts 0 µg 1 µg 2.5 µg 5µg 10µg 
Viability (%) 
Ep1 
90.56 92.00 91.21 92.06 90.66 
Viability (%) 
Ep2 
85.67 94.87 93.57 93.57 95.25 
Viability (%) 
Ep2 
94.30 91.43 91.32 90.54 92.98 
Means ± SEM 90.18 ± 2.50 92.77 ±1.06 92.03 ±0.77 92.05 ±0.87 92.9 5± 2.30 
 
The next step was to determine whether fonio extracts decreased growth rate via cell 
differentiation. For that purpose we conducted the NBT test. This test clearly 
differentiates between myeloid cells and mature cells. Premature cells cannot reduce 
nitrozolium blue dye into black-colored formazan salts. The test is very accurate when 
monocytes differentiate into macrophages; after reduction of the nitrozolium salt, the 
obtained black formazan is sequestered inside the macrophages, granulocytes and other 
cells that will further be dissolved in DMSO and ODs are measured at 540nm.  
Figure 5 shows results obtained from THP1 after they were incubated for 5 days with 
and without the fonio extracts. Fonio extracts induced differentiation (confirmed by NBT 
results) in a dose dependent manner (Figures 5) but without apparent morphological 




Bars with different letters are significantly different; a>b>c; p <0.05. 
Figure 5: NBT test of THP1 cells treated only with different concentrations of fonio 
extracts. These data are means obtained from 4 experiments.  
 
Table 5 shows the results obtained from the different combinations of THP1 cells, all 
trans retinoic acid (ATRA), Vitamin D and phorbol myristate acetate (PMA) with or 
without fonio extracts. THP1 cells were completely differentiated by ATR  alone 
although cells visibly started to undergo necrosis (fuzzy cell membrane) [Figure 7A].  
Table 5: NBT for THP1 cells with Vit D, ATRA or PMA with or without fonio extracts.  
 0 µg fonio 2.5 µg fonio P* ≤ 
Vit D (OD) 0.309 ±0.015 0.450± 0.021 0.001 
ATRA (OD) 0.246 ±0.026 0.333± 0.014 0.003 
Vit D/ATRA (OD) 0.125± 0.033 0..316± 0.030 0.001 
Vit D/ ATRA/ PMA (OD) 0.227± 0.027 0.382± 0.024 0.01 
 
THP1 cell differentiation was better achieved with the combination of ATRA and 
Vitamin D, but necrosis visibly started at day 5, recognizable by the slightly damaged cell 
membranes (Figures 8A); when fonio extracts were added, the new differentiated cells 
proliferated more since there were much more cells absorbing the formazan salt (ODs 
raising from 0.125 up to 0.316); also there are visibly more new cells in the image where 





















finely defined) [Figure 8B]. Similar results were obtained from the combination of 
ATRA/VITD/PMA and ATRA/VITD/PMA/fonio; the presence of fonio extracts induced 
proliferation and enhanced viability of the new cells with ODs raising from 0.227 to 
0.382 (9A and 9B) and pictures visibly showing a higher density of new cells with the 
fonio extracts .  
Both ATRA and vitamin D are known for inducing differentiation, whereas PMA is a 
strong mutagen to induce cell proliferation. They are widely used in NBT techniques to 
induce cell differentiation (uptake of formazan salt) first, and then the compound to be 
tested is added. If uptake of the formazan salt is increased, then differentiation capacity is 
attributed to the tested compound (Makashima et al 2003; Komoura et al 2007; Chen et al 









Figure 5A. THP1 Cells without fonio extracts after 5 days of incubation 
 




Figure 6 A: THP1 cells incubated with Vit D for 5 days, without fonio extracts 
 
Figure 6B. THP1 cells incubated with Vit D for 5 days, with fonio extracts 
After 5 days of incubation with Vit D, THP1 cells alone underwent slight morphological changes. Those 
changes were enhanced when the cells were incubated with fonio extracts. The observations were 





Figure 7A. THP1 cells incubated with ATRA for 5 days, without fonio extracts 
 
 
Figure 7B. THP1 cells incubated with ATRA for 5 days, with fonio extracts 
After 5 days of incubation with ATRA alone, THP1 cells underwent important morphological changes (Fig 
6A). Those changes were enhanced when the cells were incubated with ATRA and fonio extracts (Fig 6B). 










Figure 8B: THP1 cells incubated with Vit D and ATRA for 5 days, with fonio extracts 
When cells were incubated with both Vit and ATRA (Figure 6A), 2 observations could be made: both 
differentiation and apoptosis took place resulting in fewer but completely different cells. When cells were 
incubated with Vit D, ATRA and fonio extracts (figure 6B), 2 observations were made: differentiation and 
proliferation of the new cells. Clusters of new cells could be observed. Observations are confirmed by NBT 











Figure 9B: THP1 cells incubated with Vit D, ATRA and PMA, for 5 days, with fonio 
Experiments described in figures 6 A and B, were replicated but in the presence of PMA, a strong mitogen; 
the same results were obtained with more cells withor without fonio. More clusters are observed with the













The fonio extracts-treated CD1 mice. After acute inflammation was induced in the CD1 
mice with 5 micrograms of LPS for two hours, the fonio-fed group expressed higher
levels of IL-6 as compared to the control group (P=0.037), suggesting a successful 
initiation of the immune system, powered by T-lymphocytes and macrophages.  IL-6 is
known to be central to the immune system in response to inflammation and infection (van 
der Poll et al 1997) and is produced by T-lymphocytes and macrophages (Grimble 1996). 
The cytokine plays a major role for the survival of host cells during acute inflammation 
survival, keeping them from undergoing apoptosis (Hodge et al 2005).  And during 
infection, Ishihara and his colleagues (2003) showed that macrophages secrete quantiti s 
of IL-6 which induce intracellular signaling cascades that further lead to the production 
of other inflammatory cytokines. The same effects were observed in our study where IL-6 
production was accompanied with high levels TNF-alpha. The control group failed to 
respond after LPS challenge since they produced significantly lower levelsof IL-6 and 
TNF alpha (p= 0.037 and P=0.0001, respectively).  
Similar results were obtained in vitro: after CD1mice spleens were treatd with 1 
microgram LPS, those from the fonio-fed group produced significantly higher levels of 
IL-6 and TNF-alpha (P= 0.002 and P= 0.02, respectively). In addition, their spleen 
weights (fonio-fed group) were significantly heavier than those of the control group (P= 
0.001) after 2 hours of the LPS challenged, suggesting a higher priming rate of naïve T-
lymphocytes and more recruitment of new cells. Interestingly, the best results (highest 
levels of pro-inflammatory cytokines) were obtained with the lowest concentrations of 
fonio extracts (1 µg) for both in vivo (serum) and in vitro (spleen) experiments. 
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Therefore, fonio extracts have immune stimulatory effects and can be an excellent 
candidate as a functional food against infection.  
Another important observation was made with the CD1 mice during the first hour of the 
treatments: both control and treatments groups were moving very slowly but in the 
following hour, the fonio group started moving faster. The same observations were made 
in humans; four clinical studies demonstrated that pre-treatment of high-risk surgical 
patients with poly-[1-6]--D-glucopyranosyl-[1-3]--D-glucopyranose glucan (PGG-
glucan) supplied intravenously decreased the infection incidence and need for antibiotics, 
shortened intensive care unit length stay, and ultimately improved survival compared to  
saline placebo injection (Babineau et al 1994; Babineau et al 1994; Browder et al 1990, 
Dellinger et al 2003). Also, in all the above cited studies, patients of the treatment group 
had significantly higher serum pro-inflammatory cytokines.  
THP1 cells treated with fonio extracts. MTT Results showed a progressive reduction of 
THP1 proliferation in a dose-dependent manner. The mechanisms by which the reduction 
took place were investigated. For that purpose, the dye exclusion test was performed and 
results showed that in all tested fonio extracts concentrationsTHP1 cells conserved their 
viability above 85 % suggesting that reduction of proliferation was not apoptotic or 
necrotic and that extract did not exert cytotoxic activity.  
After the first 24 hours of incubation, reductions of 11.22 and 13.46 % in IL-8 expression 
were observed with the treatments of 2.5 and 5 µg respectively. At 48 hours, there were 
reductions of 20 and 37 %, but at 72 hours there were drastic reductions of approximately 
89 and 91% in IL-8 expression. Interestingly, when inflammation was not present, fonio 
extracts did not affect THP1 cells secretion of the cytokine since there were no significant 
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differences between the amounts of IL-8 produced by the THP1 cells alone and those of 
the THP cells treated with fonio alone. This observation was in agreement with the study 
of Brown and Gordon (2003) who noted that low molecular weight beta-glucans would 
modulate the response of cells only when they are stimulated by an inflammatory 
environment, contrary to high molecular weight beta-glucans. Although this study 
focused on inflammation, the decrease of IL-8 induced by the extracts may lead to a new 
line of research on cancers. IL-8 was found to be involved in growth and invasiveness of 
estrogen-negative breast cancer cells and promoted tumor (Freund et al 2003).  
The NBT test clearly showed that the mechanism by which fonio decreased cell 
proliferation was cell differentiation. When cells were treated with fonio extracts alone, 
the differentiation was initiated, confirmed by the results of the NBT although there was 
not a visible morphological change. Vitamin D and ATRA are known to induce cell 
differentiation. Several studies used this method to assess the capacity of a compound to 
differentiate cells (Makashima et al 2003; Komoura et al 2007; Chen et al 2009; James et 
al 1997). Cells are first incubated with ATRA alone or with its combination with Vit D 
and the ODs are recorded. Then the compound to be tested is incubated with ATRA or 
Vit D or with the combination; if a higher OD is obtained then it is concluded that the 
compound is involved in differentiation. Recently, Nurath and Finotto (2011) showed 
that IL-6 signaling was crucial for T-lymphocytes differentiation and ctivation. 
Although THP1 cells are monocytes, we can infer from the study of  Nurath and Finnotto 
that the presence of high levels of IL-6 may explain one process through which 
differentiation of the monocytes (THP1) occurs. They recently showed that IL-6 
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signaling was crucial for T-lymphocytes differentiation and activation (Nurath and 
Finotto 2011). 
As we stated above, NBT tests implied that fonio extracts alone induced THP1 cells 
differentiation in a dose-dependent manner (figure 4), but without visible morphological 
changes. The best compound that was seen to differentiate THP1 alone was ATRA, or its 
combinations with other compounds. But for unknown reasons, necrosis in THP1 cells 
started to take place with ATRA and its combinations at day 5. However, the major 
finding of this study is the capability of the fonio extracts to inhibit necrosis and to 
enhance differentiation. In all ATRA treatments, fonio extracts kept the viability of the 
new differentiated cells and allowed their proliferation. These properties can be visually 
observed when comparing figures 8A and 8B, or 9A and 9B and they are confirmed by 
the NBT results (0.125 against 0.316 and 0.227 against 0.328, respectively). 
In summary, the following are the new findings of the current study: 
a. Fonio extracts raised inflammatory cytokines in CD1 mice after inflammation was 
induced by LPS.  
b. The extracts decreased THP1 proliferation  
c. After LPS challenge, fonio-treated THP1 increased IL-6 levels but interestingly 
reduced IL-8 levels. 
d. Cell differentiation is the mechanism by which fonio decreased THP1 cell 
differention 
e. The combination of ATRA and fonio extracts completely differentiated the 
monocytes (THP1) into macrophages and other granulocytes. 
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  The limitations of our study are: It would’ve been interesting to run flow cytometry in 
order to determine the new cell strains after differentiation occurred.  
4. Conclusion  
Fonio extracts revealed a potent immuno-modulatory capacity. Just one microgram 
triggered strong effects in both spleen cells of CD1 mice and did the same with the THP1 
cells. In addition, fonio could stop proliferation rate of the THP1, a human cancer cell 
line by inducing their differentiation into macrophages, fibroblasts and granulocytes. In 
addition, the extracts drastically reduced IL-8 secretion in THP1 cells. IL-8. Those 
characteristics could pave new lines of research for the wild cereal. 
Implications/recommendations. The extracts of fonio could be used as an alternative to 
HIV patients of whom, the impaired immune system exposes them to many infections. 
Those patients took lots of antibiotics with so many adverse effects. A functional fo d 
made of the extracts may drastically reduce their antibiotics intake. Also, the extracts 
may be a serious candidate against breast cancer. 
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SUMMARY, CONCLUSIONS AND RECOMMENDATIONS 
 
Summary of findings 
The major objectives of these studies were to find out whether or not Digitaria exilis 
(fonio), a wild cereal mainly found in West Africa had the alleged traditional anti-
diabetic properties that local populations believed in. For that purpose two studies were 
undertaken: in the first one, AIN 93 (regular mice feed) was supplemented with fonio or 
rice to test their effects on KK/HIJ mice; in the second study, THP1 cells and normal 
CD1 mice were treated with fonio extracts to investigate its effects on inflammation and 
the mechanisms involved. After completion of the studies, the main findings are 
summarized below:    
a. After four months of dietary treatment, results showed that supplementation the 
diet with fonio can improve insulin resistance and glucose tolerance in KK/HIJ 
mice. 
b. Feed intake in the fonio-fed group was significantly reduced as compared to the 
rice and control groups.  
c. Supplementing the KK/HIJ mice with fonio blocked the development of their 
yellow color characteristic of the expression of the yellow agouti gene (one gene 
of obesity).  
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d. Fonio decreased plasma levels of IL-6, but not TNF-α. Decreased IL-6 will 
modulate blood levels of C-reactive protein, a marker of inflammation and risk 
factor of complications of chronic diseases including type-2 diabetes. 
e. Compared to rice, fonio also tended to decrease in vitro secretion of IL-1β and IL-
6, but not TNF-alpha by LPS activated spleen cells. IL-1β is known to induce 
apoptosis in cells of islets of Langerhans.  
f. Fonio extracts raised inflammatory cytokines in CD1 mice after inflammation was 
induced by LPS.  
g. Fonio extracts decreased THP1 proliferation  
h. After LPS challenge, THP1 cells treated with fonio extracts responded by 
expressing higher levels of IL-6, but interestingly, they produced lower levls of 
IL-8 when compared to controls. 
i. Cell differentiation but not necrosis, was the mechanism by which fonio 
decreased THP1 cell proliferation.  
j. The combination of ATRA and fonio extracts completely differentiated the 
monocytes (THP1) into macrophages and other granulocytes. This differentiation 
was further enhanced by vitamin D.   
Conclusions 
In conclusion, data suggest that fonio may modulate diabetes severity by reducing 
inflammatory cytokines and increasing insulin sensitivity. Supplementation with fonio 
blocked the development of the characteristic yellow fur of KK/HIJ mice, suggetin  the 
down-regulation of the adult-onset yellow agouti gene. Fonio extracts revealed a potent 
immuno-modulatory capacity: just one microgram triggered strong effects in both spleen 
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cells of CD1 mice and THP1 cells. Even though our studies were confined to 
investigating fonio effects on diabetes only and not cancer, it was found that fonio 
extracts could reduce proliferation rate of THP1 cells, a human cancer cell line by 
inducing their differentiation into macrophages (fibroblasts and granulocytes). In 
addition, the extracts drastically reduced IL-8 secretion in THP1 cells. Studies have 
demonstrated a strong involvement of IL-8 in breast cancer. Those characteristics could 
pave new lines of cancer research with the wild cereal. 
Implications/Recommendations 
a. A functional food made of fonio/fonio extracts should be developed and its effects 
tested on obese, pre-diabetic and diabetic people.  
b. The functional food/fonio extracts could be used as a supplement for HIV patients 
whose impaired immune system exposes them to many infections. HIV patients, contrary 
to healthy people, express low levels of pro-inflammatory cytokines when they are 
infected with pathogens. Therefore, during infection, those patients are given high doses 
of antibiotics with so many adverse effects. A functional food/fonio extracts may 
drastically reduce their antibiotics need. 
c. Because of the fact that fonio extracts reduced the proliferation of THP1 cancerell 
line, and decreased IL-8 production, their effects should be tested against breast cancer. 
Limitations 
The limitations of our study were: 
a. KK/HIJ mice were received by groups of 10 over a 2-month period forcing us into 
a slight modification of our design and protocol. After receiving the first 10 mice, 
4 were assigned to the AIN diet; 3 to the fonio-supplemented diet; and 3 to the 
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rice-supplemented diet. A month later, we received 10 more mice and 4 were 
assigned to the fonio diet and 3 to each of the other 2 diets; and so on with the 
following third group of 10 mice received (4 assigned to rice-supplemented 
diet…etc.). Some of the mice were received in fall and some at the beginning of 
spring; treatments in different seasons may generate biases. 
b. Although we had 3 groups of 20/diet, we further subdivided them in two sub-
groups to test the effects of short versus longer exposure to the diets. Therefore 
some tests (like GTT) lacked of statistical power. 
c. It would have been interesting to run flow cytometry in order to determine the 
new cell strains after differentiation occurred.  
d. Important tests such as quantification of the yellow obese gene/mRNA after 
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Appendix 1: Cell Proliferation  
Reagents and materials and required: 
Mediums, solutions, & special reagents Major sources (vendors) of these reagents and  
supplies include Sigma, Invitrogen/GIBCO, Fisher, BD Biosciences, and VWR.  
Fonio extracts : stock solution containing 1 mg/ml (refer to Annex 4 for extract 
preparation) 
Mitogens: Lipopolysaccharides (LPS) 
Concentration of stock solution: 100 µg/ml  
Use 10 µL/1 ml cell suspension (the equivalent of 1 µg/ml 
Or perform mitogen dose response before the actually study of interest. Based on past 
experience, the optimal concentration is between 1 a d 5, quite often 2.5 µg/ml.  Levels 
≥7.5 µg/ml are inhibitory. 
MTT reagent (Source Sigma): dissolve to obtain 5 mg/ml PBS.  
Filter the sample and use 25 µL/well.  
Keep at 4°C protected from light by wrapping the tube with aluminum foil.  
MTT is stable for 2 weeks (even longer) as long as it is not contaminated with cells. 
Isopranol – 0.08N HCl: solution to stop the MTT reaction: Use 50 µL/well (96 well-
plates). 
Culture medium: composed of RPMI-1640, 25 mM HEPES, 2 mmol/l L- glutamine, 0.1 
mmol/l non essential amino acids, 1 mmol/l sodium pyruvate, 50 µmol/l β-
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mercaptoethanol, 50-100 international units/ml (50,000-100,000 international units/l) 
penicillin, and 50-100 µg/ml (50-100 mg/l) streptomycin (P/S).  
Wash medium: PBS supplemented with either 0.5% or 1% BSA (bovine serum albumin), 
or 1% FCS (fetal calf serum; fetal bovine serum), and 50-100 Units/ml penicillin, 50-100 
µg/ml streptomycin (P/S).  
Red blood cells (RBCS) lysing buffer: sterile ice cold distilled water or a filtered solution 
of ammonium chloride (NH4 Cl, 8.3 g), potassium bicarbonate (KHCO3, 1.0 g), and 
EDTA (ethylene diamine tetra-acetic acid) 1.8 ml of 5% stock solution) dissolved in 1000 
ml deionized water). 
Trypan blue- 0.4% for viable cell count 
Drabkin’s reagent (reagent available) 
Kits: IL-6, IL-8, (or others based on Specific Aim of the experiment)  
Sterile 2 cc, 5 cc, and 10 cc serological pipettes. 
Pasteur pipettes; pipetors or pipet-aid 
Bench paper 
Gloves 
Sterile blue tips (1000 µL capacity); yellow tips (2-200 µL capacity) 
200 cc capacity beaker with about 100 ml 70% ethanol 
200 cc capacity beaker with saline (0.85-0.9% sodium chloride solution) to wash tissues 
such as liver, heart, kidney and lungs (tissues that may contain a lot of blood). N te: if
sodium chloride interferes with assays to be performed on these tissues, saline shall not 
be used.    
Surgical supplies (scissors, forceps) 
CO2, ether, isoflurane, or any other suitable (approved) chemicals for anesthetizing mice;  
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24 well plates (for macrocultures); 96-well plates (for cell proliferation/microculture) 
Dry ice or liquid nitrogen (if tissues need to be frozen immediately) 
Scintillation vials – 7 ml capacity with 2 ml formalin: 1/mouse (if tissues or bones have 




Refrigerated centrifuge machine (capable of achieving 500-6000 rpm or at least about 
400 x g) 
Tubes & other supplies:  
12 x 75 mm (5 ml capacity) for Hb assay: 2/mouse (2.5 ml Drabkins reagent/tube) 
2 ml Cryovials (for freezing leftover cells): 2/mouse – 1/spleen, 1/thymus – if required 
Hematocrit (Hct) tubes & clay (sealant – sealing material)   
15 ml conical centrifuge tubes (sterile) with 10 ml PBS: 2/mouse (1/Spleen, 1/thymus) 
Cell strainers: 2/mouse (1 for spleen & 1 /thymus) 
Two 3 cc or 1 cc capacity syringes (no needles): 1/spleen; 1/thymus 
CO2 incubator set at 37°C & 5% CO2: Important note: To control humidity, water must 
be put in a dish in the lower shelf of the incubator. 
12 x 75 mm (5 ml capacity): 1/spleen; sterile, with 1 ml PBS 
12 x 75 mm (5 ml capacity): 1/thymus; sterile, with 1 ml PBS 
1.5 ml capacity eppendorf tube: 1 for each tissue/mouse [heart (H); liver (L); kidney (K); 
LU (lungs)];  
1.5 ml capacity Eppendorf tube for blood sample: 1/mouse  
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1.5 ml capacity eppendorf tube for collecting plasma: 1/mouse  
400 µL or 1.5 ml capacity eppendorf tube: 1/spleen cell counts 
400 µL or 1.5 ml capacity eppendorf tube: 1/mouse for WBC (white blood cells) counts 
400 µL or 1.5 ml capacity eppendorf tubes: 1/mouse for thymocyte counts 
Composition of some reagents 
Beta-mercapto-ethanol: 
Stock solution A: To make 1 M, mix 0.5 ml with 6.6 ml distilled water. 
Stock solution B: To make 50 mM, mix 5 ml of stock solution A with 95 ml distilled 
water 
For culture medium requiring 50 µM β-mercaptoethanol, add 100 µL to 99.9 ml of 
culture medium (final volume 100 ml medium). 
Composition of phosphate buffered saline (PBS) 1X (working solution): 
0.23 g NaH2PO4 (anhydrous) (1.9 mM) 
1.15 g Na2H PO4 (anhydrous) (8.1 mM) 
9 g NaCl (154 mM) 
Add 900 ml distilled deionized water 
Dissolve all salts 
Adjust pH to 7.4 by adding drops of either 1M NaOH or 1M HCl  
Bring total volume to 1000 ml by adding more deionized water 
Add fetal calf serum (FCS) and antibiotics (P/S, 50-100 units (add 1-4% glucose as 
desired) 




Appendix 2: Mice treatment 
Anesthetize the mouse by CO2, ether, or isoflurane inhalation 
Weigh the mouse and record the info on the chart 
Draw as much blood as possible by retro-orbital plexus or other methods and transfero 
heparin containing 1.5 ml conical tubes. If serum is desired, transfer the blood to a tube 
without anticoagulant. 
Important Note: To limit hemolysis, keep tubes at room temperature.  
Centrifuge vials or tubes no later than 60 min.  
Collect plasma or serum and transfer to new 1.5 ml eppendorf vials (tubes) and freeze at -
80°C until used for various assays.  
If the volume allows, the plasma/serum can be split in 2 trace elements, etc) hav  to be 
done at different times. 
After drawing blood, “flood - wash” the mouse abdomen with 70% EtOL 
Remove the spleen under sterile conditions and transfer immediately to a 12 x 75 mm 
culture tube containing 1 mL PBS (sterile).  
Weigh immediately and transfer the tube to 4°C (ice bucket).  
NOTE: Never leave spleen in a tube without PBS or medium because it will undergo 
autolysis. 
Remove the thymus also under sterile conditions and transfer to sterile 12 x 75 mm tube, 
weigh, and transfer to 4°C (ice bucket). 
Remove the liver, heart, kidneys, and lungs and transfer each to pre-weighed 1.5 ml 
capacity eppendorf tubes. (Rinse extra blood in saline or distilled water.) 
Weigh and immediately transfer to liquid nitrogen or dry ice.  
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If required, cut one or both front and back legs, remove skin and muscle and freeze in 
liquid nitrogen or at -80°C. Legs may also be frozen with skin and muscle. Tibia and 
femurs may also be collected and transferred to formalin for bone studies. 
 
Preparation of Spleen Single cell Suspension: Except with centrifugation, all steps are to 
be performed under a tissue culture hood. 
Prepare single cell suspension by standard techniques: 
Gently grind the spleen on a sterile cell strainer placed on a 40 cc capacity beaker or a 50 
cc capacity centrifuge tube with use of the inner portion of a 1 cc or 3 cc syringe.  
Wash the cell strainer with 10 ml PBS and collect the fluid and transfer to a 15 ml conical 
sterile centrifuge tube. 
Centrifuge tubes at 1200 rpm, 4°C for 10 min. 
Decant 
Resuspend the cell pellet in 1 ml, sterile ice cold deionized water 
Mix the cell pellet by inverting tube or shaking (Do not vortex). This step mustbe done 
rapidly if not cells will form clumps. 
Incubate tubes on ice for 20-60 sec (average 30 sec). Incubation time varies with the s ze 
of the pellet. But never leave cells in water for more than 60 sec at a time. 
Fill the tube with 10 ml ice cold PBS supplemented with either 0.5-1% BSA or FCS.  
Mix rapidly and centrifuge as explained under Step 11.  





Resuspend pellet in 2 ml ammonium chloride solution 
Incubate at room temperature for 5 min 
Add 8 ml of wash (PBS/FCS/P/S) medium to each tube 
Centrifuge at 4°C, 400 x g or 1200 rpm for 10 min. 
Decant.  
If the cell pellet is still red, repeat Steps 13-17.  
Otherwise, resuspend the cell pellet in 1-3 ml culture medium. 
Important notes: 2.5% FCS supplemented culture medium is recommended when dealing 
with spleens from iron deficient animals. However, when iron or other trace elements 
present in serum are not variables under study, 10% FCS supplemented medium is 
recommended. 
Mix the cell pellet either by shaking the tubes or with a pipet.                                           
To avoid clumping, this step must be done very rapidly.   
To perform total and viable cell counts, combine 10 µL of cell suspension and 90 µL of 
0.4% trypan blue (or 20 µl of cell suspension and 180 µl trypan blue in an eppendorf 
tube. (This is the equivalent of 1:10 dilution). 
Transfer cells to a haemocytometer.  
Count the number of dead (blue) and live (clear) cells in the center square and/or center 
plus 4 corners of one side of the hemocytometer. 
Calculate viable cell concentration as follows: 
N x 106 / ml = (number of viable cells counted    x 106  
Number of squares counted x 10 
142 
 
If a 1: 20 dilution was done, the cell concentration obtained above should be multiplied 
by 2. 
If a 1:5 dilution was made (10 µL cells plus 40 µL trypan blue or 20 µL plus 80 µL), the 
cell concentration should be multiplied by 0.5 (or divided by 2). 
If cells were counted only in one square, the denominator will be 1 x 10.  
 
Appendix 3: Macrocultures for secretion 
Transfer 2 x 106 viable cells to each well on a 24-well plate (4 cultures/spleen) according 
to the chart shown below. 
Add 10 µL, 25 µL, 50 µL, 100 µL mitogens (Con A, PWM, LPS, sterile stock solution of 
100 µg/ml), or culture medium (for non-activated cells). 
Bring total volumes to 1 ml with complete RPMI-1640-25 mM HEPES medium (see 
composition page 1).  
The final concentration of mitogens is 1 µg/ml, 2.5 µg/ml, 5 µg/ml, and 10 µg/ml when 
10 µL, 25 µL, 50 µL, 100 µL of stock solutions were used, respectively. 
IMPORTANT NOTE: Mitogen Dose Response is done only with Preliminary 
Experiment or when a New Lot # of a Mitogen is received. For The purpose of the 
experiment, you shall perform a mitogen dose response! 
After mixing cells by tilting the plate, transfer 24-well plates to a CO2 incubator set at 
37°, 5% CO2, in a humidified atmosphere. 




Collect the supernatant and transfer aliquots (about 500 µL) to 1.5 ml capacity eppendorf 
vials.  
Since cytokine secretion is time dependent and varies with the type of cytokine, it may be 
a good idea to perform a time dependent response (8 h, 12 h, 24 h, 48 h, or 72 h.   
Important Note: Incubate plates for 72 and Record the information in your research 
notebook!  
Vials need not be sterile but must be clean and not previously used. 
Vials with supernatants must be kept on ice or cold blue box. 
Care must be taken not to mix the cell pellet because the pellets will affect cytokine 
levels or volume at the time of cytokine assay.  
Freeze supernatants at -80°C until needed for cytokine and immunoglobulin assays. 
Cell Proliferation by Either MTT Test or 3H-thymidine Uptake. 
Label sterile several tubes per spleen (12 x 75 mm culture tubes). The # of tubes needed 
depends on the number of cultures or mitogen doses to be tested. 
Transfer 1 x 106 viable cells to each.  
Do not add any mitogen to tube 1: baseline or non-activated cells. 
Add 10 µL, 25 µL, 50 µL, 100 µL mitogens (Con A, PWM, LPS, sterile stock solution of 
100 µg/ml) to tubes a to X. 
Bring total volume per tube to 1000 µL by adding culture medium. 
For baseline culture, also add medium to up to 1000 µL.  
Mix cells and mitogens by shaking the tubes – DO NOT VORTEX.  
Transfer 200 µL of cells to 3 wells. 
Incubate plates in CO2 incubator, 5% CO2, 37°C, in a humidified atmosphere. 
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After 68 h, add 25 µL of 5 mg/ml MTT sterile solution (pre-warmed at 37°C for 5 min or 
left at room temperature for 15-30 min protected from light).  
Important Note: Turn the light off in the tissue culture hood while adding MTT solution 
to wells. 
2.40 ml of MTT are needed per 96-well plate. To be on a safe side, for each 96-well 
plate, remove 3.0 ml of MTT from the flask and transfer to a new small tube for 
immediate use.  
To avoid contamination, Do not return used MTT to the original container or flask.  
Also to avoid cross contamination, use 1 pipet tip per well or use 8-channel pipet for fast 
delivery of solution. 
For MTT blank, transfer 200 µL of culture medium (no cells) to a set of 12 wells and 
incubate the plate in parallel to the microcultures. Add MTT and/or isopropanol-HCl 
solution as for microcultures.  
To avoid waste of 96-well plates, one can also transfer 400 µL culture medium to 3-4 12 
x 75 mm tubes.  
At appropriate times, add 50 µL MTT to each tube and 100 µL isopropanol-HCl solution. 
Then mix the tubes and transfer 275 µL to 1 well/tube on a non-sterile but clean 96-well 
plate.  
The reading of OD is done as for microcultures.  
Cover the plate with a piece of aluminum foil. 
After 4 h of further incubation in CO2 incubator, add 50 µL isopropanol-HCL solution to 
each well.  
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Seal the plate with transparent paper and read optical density (OD) according t  protocol 
(570 nm with a reference wavelength of 650nm. (Some investigators have also used 540 
nm for OD determination.) 
Calculate the mean OD of triplicate wells and the ratio of OD obtained with mitogen over 
baseline (culture without mitogen).  
Express the results as percent of background. 
Cryo-preservation of unused cells. 
Prepare freezing medium by adding 0.5 ml of DMSO (dimethyl sulfoxide) to 9.5 ml 
culture medium. Filter the medium and keep on ice. 
Note: Freezing medium is prepared just before use and shall not be stored for more than 
60 min. 
Centrifuge remaining spleen single cell suspensions at 1200 rpm, 4°C for 10 min. 
Resuspend the cell pellet in 1-2 ml or about 5 x 106 cells/vial (sterile cryovial, 2 ml 
capacity). 
Transfer the cells into sterile cryovials and incubate at on ice for 30 min. 
Transfer to liquid nitrogen immediately or -80°C overnight but not longer. If spleen cells 
are kept at -80°C for more than 24 h, cell viability significantly decreases. 
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